FRED HUTCHINSON CANCER RESEARCH CENTER: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization: FRED HUTCHINSON CANCER RESEARCH CENTER (EIN 23-7156071)
Tax period: 2011-07-01 to 2012-06-30
Filed: 2013-05-10
IRS object ID: 201311309349301841
Schema version: 2011v1.5
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule K
Schedule K
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2013-05-10T14:44:00-05:00	Timestamp
Tax Period End Date	2012-06-30	TaxPeriodEndDate

Preparer Firm PreparerFirm

Field	Value	IRS element (for citing)
EIN	911194016	EIN

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	CLARK NUBER PS	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	10900 NE 4TH STREET SUITE 1700	AddressLine1
City	BELLEVUE	City
State	WA	State
ZIP Code	98004	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2011-07-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	237156071	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	FRED HUTCHINSON CANCER RESEARCH CENTER	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Control	FRED	NameControl
Phone	2066674876	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1100 FAIRVIEW AVENUE NORTH	AddressLine1
City	SEATTLE	City
State	WA	State
ZIP Code	981091024	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	RANDALL C MAIN	Name
Title	CFO	Title
Phone	2066674876	Phone
Date Signed	2013-05-10	DateSigned
Authorize Third Party	1	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Name	SARA ELIZABETH J HYRE	Name
PTIN	P00235495	PTIN
Phone	4254544919	Phone

Field	Value	IRS element (for citing)
Tax Year	2011	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	LAWRENCE COREY	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	1100 FAIRVIEW AVENUE NORTH	AddressLine1
City	SEATTLE	City
State	WA	State
ZIP Code	981091024	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	523405356	GrossReceipts
Group Return For Affiliates	0	GroupReturnForAffiliates
Organization501c3	X	Organization501c3
Web Site	WWW.FHCRC.ORG	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1971	YearFormation
State Legal Domicile	WA	StateLegalDomicile
Activity Or Mission Description	THE ELIMINATION OF CANCER AND RELATED DISEASES AS CAUSES OF HUMAN SUFFERING AND DEATH.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	18	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	17	NbrIndependentVotingMembers
Total Nbr Employees	3132	TotalNbrEmployees
Total Nbr Volunteers	400	TotalNbrVolunteers
Total Gross UBI	0	TotalGrossUBI
Net Unrelated Business Txbl Income	-37143	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	388454000	ContributionsGrantsPriorYear
Contributions Grants Current Year	369203443	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	51692311	ProgramServiceRevenuePriorYear
Program Service Revenue CY	59744175	ProgramServiceRevenueCY
Investment Income Prior Year	9756524	InvestmentIncomePriorYear
Investment Income Current Year	4138847	InvestmentIncomeCurrentYear
Other Revenue Prior Year	20703489	OtherRevenuePriorYear
Other Revenue Current Year	9290457	OtherRevenueCurrentYear
Total Revenue Prior Year	470606324	TotalRevenuePriorYear
Total Revenue Current Year	442376922	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	80189368	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	79888530	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	214220175	SalariesEtcPriorYear
Salaries Etc Current Year	224888268	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	59204	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	83076	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	6913589	TotalFundrsngExpCurrentYear
Other Expense Prior Year	131738614	OtherExpensePriorYear
Other Expenses Current Year	131299306	OtherExpensesCurrentYear
Total Expenses Prior Year	426207361	TotalExpensesPriorYear
Total Expenses Current Year	436159180	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	44398963	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	6217742	RevenuesLessExpensesCY
Total Assets BOY	714148481	TotalAssetsBOY
Total Assets EOY	714068907	TotalAssetsEOY
Total Liabilities BOY	461116144	TotalLiabilitiesBOY
Total Liabilities EOY	481168125	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	253032337	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	232900782	NetAssetsOrFundBalancesEOY
Info In Schedule O Part III	X	InfoInScheduleOPartIII
Mission Description	FRED HUTCHINSON CANCER RESEARCH CENTER'S (THE CENTER) MISSION IS THE ELIMINATION OF CANCER AND RELATED DISEASES AS CAUSES OF HUMAN SUFFERING AND DEATH. THE CENTER CONDUCTS RESEARCH TO IMPROVE PREVENTION AND TREATMENT OF CANCER AND RELATED DISEASES.	MissionDescription
Significant New Program Services	0	SignificantNewProgramServices
Significant Change	0	SignificantChange
Expense	134810746	Expense
Grants	44670654	Grants
Revenue	19609323	Revenue
Description	VACCINE AND INFECTIOUS DISEASE DIVISION:THE VACCINE AND INFECTIOUS DISEASE DIVISION, VIDD, WAS ESTABLISHED BY THE FRED HUTCHINSON CANCER RESEARCH CENTER, FIRST AS AN INSTITUTE IN 2007 AND AS A SCIENTIFIC DIVISION OF THE CENTER IN 2010, TO ADDRESS THE GROWING NEED FOR TREATMENT AND PREVENTION STRATEGIES FOR INFECTIOUS DISEASES WORLDWIDE. BY INTEGRATING BIOMETRIC, LABORATORY, AND CLINICAL SCIENCE, THE RESEARCHERS AT VIDD AIM TO DEVELOP NOVEL VACCINES FOR INFECTIOUS DISEASES THAT THREATEN GLOBAL HEALTH, TO SHED LIGHT ON THE WORKINGS OF THE HUMAN IMMUNE SYSTEM, AND TO DEVELOP NOVEL TREATMENT AND PREVENTION STRATEGIES TO LESSEN THE BURDEN OF INFECTIOUS DISEASES AND CANCERS CAUSED BY INFECTION, PARTICULARLY IN THE IMMUNOCOMPROMISED HOST.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	114559825	Expense
Grants	22039124	Grants
Revenue	16663661	Revenue
Description	PUBLIC HEALTH SCIENCES DIVISION: THE GOAL OF THE PUBLIC HEALTH SCIENCES DIVISION IS TO IDENTIFY STRATEGIES THAT WOULD ULTIMATELY REDUCE THE INCIDENCE OF AND MORTALITY FROM CANCER AND OTHER DISEASES. THE PUBLIC HEALTH SCIENCES DIVISION IS MADE UP OF SIX MAJOR PROGRAMS: BIOSTATISTICS & BIOMATHEMATICS, CANCER PREVENTION, COMPUTATIONAL BIOLOGY, EPIDEMIOLOGY, AND TRANSLATIONAL RESEARCH.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	99963257	Expense
Grants	7438090	Grants
Revenue	14540471	Revenue
Description	CLINICAL RESEARCH DIVISION: FROM LABORATORY BENCH TO BEDSIDE, THE CLINICAL RESEARCH DIVISION WORKS TO DEVELOP AND ANALYZE NEW TREATMENTS FOR CANCERS AND OTHER DISEASES.	Description

Activity Other ActivityOther (2 entries)

ExpenseExpense	GrantsGrants	RevenueRevenue	DescriptionDescription
31279005	4839183	4549786	HUMAN BIOLOGY DIVISION:THE MISSION OF THE HUMAN BIOLOGY DIVISION IS TO CULTIVATE INTERDISCIPLINARY RESEARCH TO ADVANCE UNDERSTANDING OF HUMAN BIOLOGY AND THE COMPLEX PROBLEMS OF NEOPLASIA AND OTHER HUMAN DISEASES. THE DIVISION IS STRUCTURED TO FOSTER LABORATORY-BASED AND COMPUTATIONAL RESEARCH AT THE INTERFACE OF BASIC, CLINICAL, AND POPULATION SCIENCES. DENISE GALLOWAY IS THE INTERIM DIRECTOR OF HUMAN BIOLOGY.
30118171	901479	4380934	BASIC SCIENCES DIVISION: THE BASIC SCIENCES DIVISION AT THE FRED HUTCHINSON CANCER RESEARCH CENTER WAS FOUNDED IN 1981 WITH THE GOAL OF PROVIDING A UNIQUE AND EXCITING ENVIRONMENT TO FOSTER CREATIVE AND GROUNDBREAKING RESEARCH. THE DIVISION CONSISTS OF 27 LABORATORIES, EACH WORKING IN DIVERSE AREAS RELATED TO ALL ASPECTS OF BIOLOGY. THE LABS EMPLOY STRUCTURAL, GENETIC, MOLECULAR, CELLULAR, DEVELOPMENTAL, AND EVOLUTIONARY BIOLOGY METHODS TO ADDRESS UNRESOLVED QUESTIONS IN BIOLOGY USING A WIDE RANGE OF MODEL SYSTEMS.

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	61397176	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	5740662	TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev	8930720	TotalOfOtherProgramServiceRev
Total Program Service Expense	410731004	TotalProgramServiceExpense
Described In501 C3	1	DescribedIn501C3
Schedule B Required	1	ScheduleBRequired
Political Activities	0	PoliticalActivities
Lobbying Activities	1	LobbyingActivities
Subject To Proxy Tax	0	SubjectToProxyTax
Donor Advised Funds	0	DonorAdvisedFunds
Conservation Easements	0	ConservationEasements
Collections Of Art	1	CollectionsOfArt
Credit Counseling	0	CreditCounseling
Term Or Permanent Endowments	1	TermOrPermanentEndowments
Report Land Bldg Equip	1	ReportLandBldgEquip
Report Invest Oth Securities	1	ReportInvestOthSecurities
Report Prog Rel Invest	1	ReportProgRelInvest
Report Other Assets	0	ReportOtherAssets
Report Other Liabilities	1	ReportOtherLiabilities
Report Fin48 Footnote	0	ReportFin48Footnote
Independent Audit Financial Stmt	0	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	1	ConsolidatedAuditFinancialStmt
School	0	School
Foreign Office	0	ForeignOffice
Foreign Activities	1	ForeignActivities
More Than5000 K To Organizations	1	MoreThan5000KToOrganizations
More Than5000 K To Individuals	0	MoreThan5000KToIndividuals
Professional Fundraising	1	ProfessionalFundraising
Fundraising Activities	1	FundraisingActivities
Gaming	1	Gaming
Hospital	0	Hospital
Grants To Organizations	1	GrantsToOrganizations
Grants To Individuals	0	GrantsToIndividuals
Schedule J Required	1	ScheduleJRequired
Tax Exempt Bonds	1	TaxExemptBonds
Invest Tax Exempt Bonds	0	InvestTaxExemptBonds
Escrow Account	1	EscrowAccount
On Behalf Of Issuer	0	OnBehalfOfIssuer
Excess Benefit Transaction	0	ExcessBenefitTransaction
Prior Excess Benefit Transaction	0	PriorExcessBenefitTransaction
Loan To Officer Or DQP	0	LoanToOfficerOrDQP
Grant To Related Person	0	GrantToRelatedPerson
Bsnss Rltnshp With Organization	0	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	0	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	1	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	1	DeductibleNonCashContributions
Deductible Contributions Of Art	1	DeductibleContributionsOfArt
Terminated	0	Terminated
Partial Liquidation	0	PartialLiquidation
Disregarded Entity	0	DisregardedEntity
Related Entity	1	RelatedEntity
Related Org Controlled Entity	1	RelatedOrgControlledEntity
Transaction Related Entity	0	TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org	0	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	0	ActivitiesConductedPartnership
Schedule O Required	1	ScheduleORequired
Number Forms Transmitted With1096	546	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	1	ComplianceWithBackupWitholding
Number Of Employees	3132	NumberOfEmployees
Employment Tax Returns Filed	1	EmploymentTaxReturnsFiled
Unrelated Business Income	0	UnrelatedBusinessIncome
Foreign Financial Account	1	ForeignFinancialAccount
Name Of Foreign Country	UG	NameOfForeignCountry
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTrans
Taxable Party Notification	0	TaxablePartyNotification
Non Deductible Contributions	0	NonDeductibleContributions
Quid Pro Quo Contributions	1	QuidProQuoContributions
Quid Pro Quo Disclosure	1	QuidProQuoDisclosure
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOf
Funds To Pay Premiums	0	FundsToPayPremiums
Premiums Paid	0	PremiumsPaid
Indoor Tanning Services	0	IndoorTanningServices
Info In Schedule O Part VI	X	InfoInScheduleOPartVI
Nbr Voting Governing Body Members	18	NbrVotingGoverningBodyMembers
Number Independent Voting Members	17	NumberIndependentVotingMembers
Family Or Business Relationship	0	FamilyOrBusinessRelationship
Delegation Of Management Duties	0	DelegationOfManagementDuties
Changes To Organizing Docs	0	ChangesToOrganizingDocs
Material Diversion Or Misuse	0	MaterialDiversionOrMisuse
Members Or Stockholders	0	MembersOrStockholders
Election Of Board Members	0	ElectionOfBoardMembers
Decisions Subject To Approval	0	DecisionsSubjectToApproval
Minutes Of Governing Body	1	MinutesOfGoverningBody
Minutes Of Committees	1	MinutesOfCommittees
Officer Mailing Address	0	OfficerMailingAddress
Local Chapters	0	LocalChapters
Form990 Provided To Governing Body	1	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	1	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	1	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	1	RegularMonitoringEnforcement
Whistleblower Policy	1	WhistleblowerPolicy
Document Retention Policy	1	DocumentRetentionPolicy
Compensation Process CEO	1	CompensationProcessCEO
Compensation Process Other	1	CompensationProcessOther
Investment In Joint Venture	0	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RANDALL C MAIN	BusinessNameLine1

Field	Value	IRS element (for citing)
Telephone Number	2066674876	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	1100 FAIRVIEW AVENUE NORTH	AddressLine1
City	SEATTLE	City
State	WA	State
ZIP Code	981091024	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (41 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	OfficerOfficer	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee
STEVE DAVIS
TRUSTEE, CHAIR	5.00	X	X	0	0	0
DOUGLAS WILLIAMS
TRUSTEE, VICE CHAIR	3.00	X	X	0	0	0
RICHARD ANDERSON
TRUSTEE, SECRETARY	3.00	X	X	0	0	0
KARL EGE
TRUSTEE, TREASURER	6.00	X	X	0	0	0
HOLLIS DILLON
TRUSTEE	1.00	X		0	0	0
KAREN GLOVER
TRUSTEE	2.00	X		0	0	0
STEPHEN GRAHAM
TRUSTEE	1.00	X		0	0	0
RONALD HOWELL
TRUSTEE	1.00	X		0	0	0
HENRY JAMES
TRUSTEE	1.00	X		0	0	0
RICHARD MCCUNE
TRUSTEE	2.00	X		0	0	0
ROBERT NELSEN
TRUSTEE	1.00	X		0	0	0
PETER NEUPERT
TRUSTEE	1.00	X		0	0	0
CHARLES NOLAN
TRUSTEE	3.00	X		0	0	0
PAULA REYNOLDS
TRUSTEE	3.00	X		0	0	0
JAMES SINEGAL
TRUSTEE	1.00	X		0	0	0
VIJAY VASHEE
TRUSTEE	1.50	X		0	0	0
DOUGLAS WALKER
TRUSTEE, IMMEDIATE PAST CHAIR	6.00	X		0	0	0
RICK KOFFEY
TRUSTEE	5.00	X		0	0	0
LAWRENCE COREY MD
PRESIDENT & DIRECTOR	40.00		X	779106	0	45396
FREDERICK R APPELBAUM MD
SR VP & DIR, CLIN RES DIV	40.00		X	637779	0	44646
JANELL E BALDWIN
VP, SHARED RESOURCES	40.00		X	223707	0	36040
ANTHONY J BOZZUTI
VP & CHIEF INFORMATION OFFICER	40.00		X	280412	0	48361
JONATHAN A COOPER PHD
SR VP & DIR, BASIC SCIENCE	40.00		X	282131	0	42684
SUSAN C DOLBERT PHD
VP & DIR, DEVELOPMENT	40.00		X	183580	0	3060
LINDA L GAINER
VP, EXTERNAL AFFAIRS & COMM	40.00		X	248902	0	39739
DENISE GALLOWAY PHD
ACTING SR VP & DIR, HUMAN BIOLOGY	40.00		X	280411	0	43604
MARK T GROUDINE MD PHD
SR VP & DEPUTY DIR, FHCRC	40.00		X	537578	0	45318
RANDALL C MAIN
VP & CHIEF FINANCIAL OFFICER	40.00		X	389545	0	45222
MARGARET JULIANA MCELRATH MD PHD
SR VP & CO-DIR, VIDD	40.00		X	312402	0	43008
ULRICH W MUELLER PHD
VP, INDST REL & CLIN RES SUPT	40.00		X	264166	0	48244
HOWARD ALBERT NACHTRIEB
VP, HUMAN RESOURCES	40.00		X	248893	0	48138
ROSS L PRENTICE PHD
SR VP & DIR, PHS	40.00		X	414412	0	45279
SCOTT N RUSCH
VP, OPERATIONS & FACILITIES	40.00		X	206791	0	39762
DOUGLAS J SHAEFFER
VP, GENERAL COUNSEL	40.00		X	335080	0	45507
MYRA H TANITA
EXEC VP & COO	40.00		X	489704	0	40138
STEVEN G SELF PHD
CO-DIR, VIDD	40.00			290841	0	44420	X
SAMIR M HANASH MD
FULL MEMBER- FACULTY	40.00			337366	0	43774		X
MARTIN A CHEEVER MD
FULL MEMBER- FACULTY	40.00			287195	0	41796		X
IRWIN D BERNSTEIN MD
FULL MEMBER- FACULTY	40.00			307683	0	42614		X
JANET LEE STANFORD MD
FULL MEMBER- FACULTY	40.00			266946	0	48447		X
BRIAN J REID MD
FULL MEMBER- FACULTY	40.00			265064	0	44947		X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	7869694	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	0	TotalReportableCompFrmRltdOrgs
Total Other Compensation	970144	TotalOtherCompensation
Number Individuals GT100 K	345	NumberIndividualsGT100K
Formers Listed	0	FormersListed
Total Comp GT150 K	1	TotalCompGT150K
Compensation From Other Sources	0	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation	Address Line1AddressOfContractor/AddressForeign/AddressLine1	CityAddressOfContractor/AddressForeign/City	Province Or StateAddressOfContractor/AddressForeign/ProvinceOrState	CountryAddressOfContractor/AddressForeign/Country	Postal CodeAddressOfContractor/AddressForeign/PostalCode
SEATTLE CANCER CARE ALLIANCE
825 EASTLAKE AVE E	SEATTLE	WA	98109	PATIENT CARE SERVICES	1607937
METROPOLITAN BUILDING MAINTENANCE CO
3829 AURORA AVE N	SEATTLE	WA	98103	MAINTENANCE SERVICES	1278518
GREEN RUBINO
1938 FAIRVIEW AVE E STE 200	SEATTLE	WA	98102	MARKETING SERVICES	1073452
BARC
				RESEARCH SERVICES	875442	FIRST FLOOR NAPIE	JOHANNESBURG	WESTERN CAPE	SF	2092 ZAF
UNIVERSITY OF CF
12424 RESEARCH PKWY SUITE 300	ORLANDO	FL	328263249	RESEARCH SERVICES	826894

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	59	NumberOfContractorsGT100K
Federated Campaigns	725880	FederatedCampaigns
Fundraising Events	4589884	FundraisingEvents
Government Grants	328727322	GovernmentGrants
All Other Contributions	35160357	AllOtherContributions
Noncash Contributions	6261189	NoncashContributions
Total Contributions	369203443	TotalContributions

Program Service Revenue ProgramServiceRevenue (3 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	Related Or Exempt Function IncomeRelatedOrExemptFunctionIncome
INTERAFFILIATE AGMTS	541711	36737557	36737557
RESEARCH ACTIVITIES	541711	12467368	12467368
PATIENT SVCS AT SCCA	622110	10539250	10539250

Field	Value	IRS element (for citing)
Total Program Service Revenue	59744175	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	3866859	TotalRevenueColumn
Exclusion	$3,866,859	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	250515	TotalRevenueColumn
Exclusion	$250,515	ExclusionAmount

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	6511134	TotalRevenueColumn
Exclusion	$6,511,134	ExclusionAmount

Gross Rents GrossRents

Field	Value	IRS element (for citing)
Real	3314050	Real

Less Rental Expenses LessRentalExpenses

Field	Value	IRS element (for citing)
Real	0	Real

Rental Income Or Loss RentalIncomeOrLoss

Field	Value	IRS element (for citing)
Real	3314050	Real

Net Rental Income Or Loss NetRentalIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	3314050	TotalRevenueColumn
Exclusion	$3,314,050	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	79618000	Securities
Other	43148	Other

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	79639675	Securities
Other	0	Other

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	-21675	Securities
Other	43148	Other

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	21473	TotalRevenueColumn
Exclusion	$21,473	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Fundraising Events	771977	GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events	4589884	CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses	1375259	FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

Field	Value	IRS element (for citing)
Total Revenue Column	-603282	TotalRevenueColumn
Exclusion	-$603,282	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Gaming	82055	GrossIncomeGaming
Gaming Direct Expenses	13500	GamingDirectExpenses

Net Income From Gaming NetIncomeFromGaming

Field	Value	IRS element (for citing)
Total Revenue Column	68555	TotalRevenueColumn
Exclusion	$68,555	ExclusionAmount

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	442376922	TotalRevenueColumn
Related Or Exempt Function Income	59744175	RelatedOrExemptFunctionIncome
Unrelated Business Revenue	0	UnrelatedBusinessRevenue
Exclusion	$13,429,304	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	72416568	Total
Program Services	72416568	ProgramServices

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	7471962	Total
Program Services	7471962	ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	7369222	Total
Program Services	3753854	ProgramServices
Management And General	3245465	ManagementAndGeneral
Fundraising	369903	Fundraising

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	171696733	Total
Program Services	137705120	ProgramServices
Management And General	30468184	ManagementAndGeneral
Fundraising	3523429	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	12717391	Total
Program Services	10337108	ProgramServices
Management And General	2101343	ManagementAndGeneral
Fundraising	278940	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	19854451	Total
Program Services	16072805	ProgramServices
Management And General	3347817	ManagementAndGeneral
Fundraising	433829	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	13250471	Total
Program Services	10591228	ProgramServices
Management And General	2379315	ManagementAndGeneral
Fundraising	279928	Fundraising

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	1371466	Total
Program Services	14948	ProgramServices
Management And General	1356518	ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	275916	Total
Program Services	14126	ProgramServices
Management And General	261790	ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	140528	Total
Management And General	140528	ManagementAndGeneral

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	83076	Total
Fundraising	83076	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	666607	Total
Management And General	666607	ManagementAndGeneral

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	27081720	Total
Program Services	11729519	ProgramServices
Management And General	14645253	ManagementAndGeneral
Fundraising	706948	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	392748	Total
Management And General	320523	ManagementAndGeneral
Fundraising	72225	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	3308024	Total
Program Services	1605139	ProgramServices
Management And General	1543327	ManagementAndGeneral
Fundraising	159558	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	2691966	Total
Management And General	2691966	ManagementAndGeneral

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	11189330	Total
Program Services	171875	ProgramServices
Management And General	11017455	ManagementAndGeneral

Travel Travel

Field	Value	IRS element (for citing)
Total	2857329	Total
Program Services	2193552	ProgramServices
Management And General	538069	ManagementAndGeneral
Fundraising	125708	Fundraising

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	642839	Total
Program Services	531458	ProgramServices
Management And General	91199	ManagementAndGeneral
Fundraising	20182	Fundraising

Interest Interest

Field	Value	IRS element (for citing)
Total	14126140	Total
Program Services	10591363	ProgramServices
Management And General	3534777	ManagementAndGeneral

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	25736149	Total
Program Services	22641146	ProgramServices
Management And General	3095003	ManagementAndGeneral

Insurance Insurance

Field	Value	IRS element (for citing)
Total	1537403	Total
Management And General	1537403	ManagementAndGeneral

Other Expenses OtherExpenses (3 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
RESEARCH SUPPLIES	22316977	22316977
EQUIP. RENT & MAINT.	6440469	2476871	3899015	64583
ALLOC OF INDIRECT COSTS	0	70386976	-70386976

All Other Expenses AllOtherExpenses

Field	Value	IRS element (for citing)
Total	10523695	Total
Program Services	7708409	ProgramServices
Management And General	2020006	ManagementAndGeneral
Fundraising	795280	Fundraising

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	436159180	Total
Program Services	410731004	ProgramServices
Management And General	18514587	ManagementAndGeneral
Fundraising	6913589	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	9037	BOY
EOY	4275	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	61510742	BOY
EOY	32986577	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	34026493	BOY
EOY	30959498	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	18046009	BOY
EOY	17375292	EOY

Other Notes Loans Receivable Net OtherNotesLoansReceivableNet

Field	Value	IRS element (for citing)
BOY	621757	BOY
EOY	660124	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	1446837	BOY
EOY	1724061	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	680995194	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	324915036	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	325355893	BOY
EOY	356080158	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	125674643	BOY
EOY	99628066	EOY

Investments Other Securities InvestmentsOtherSecurities

Field	Value	IRS element (for citing)
BOY	40827536	BOY
EOY	62539963	EOY

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
BOY	71213967	BOY
EOY	77786370	EOY

Intangible Assets IntangibleAssets

Field	Value	IRS element (for citing)
BOY	2530782	BOY
EOY	2482655	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	32884785	BOY
EOY	31841868	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	714148481	BOY
EOY	714068907	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	35760069	BOY
EOY	41732382	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	26711012	BOY
EOY	31465334	EOY

Tax Exempt Bond Liabilities TaxExemptBondLiabilities

Field	Value	IRS element (for citing)
BOY	372159052	BOY
EOY	367774147	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	26486011	BOY
EOY	40196262	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	461116144	BOY
EOY	481168125	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	162996337	BOY
EOY	141600782	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	38223000	BOY
EOY	38055000	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	51813000	BOY
EOY	53245000	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	253032337	BOY
EOY	232900782	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	714148481	BOY
EOY	714068907	EOY

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	X	InfoInScheduleOPartXI
Reconcilation Revenue Expenses	6217742	ReconcilationRevenueExpenses
Reconcilation Other Changes	-26349297	ReconcilationOtherChanges
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	0	AccountantCompileOrReview
FS Audited	1	FSAudited
Audit Committee	1	AuditCommittee
Financial Statement Consolidated	X	FinancialStatementConsolidated
Federal Grant Audit Required	1	FederalGrantAuditRequired
Federal Grant Audit Performed	1	FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	321146537	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	309432567	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	345330959	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	388454000	CurrentTaxYearMinus1Year
Current Tax Year	369203443	CurrentTaxYear
Total	1733567506	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	321146537	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	309432567	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	345330959	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	388454000	CurrentTaxYearMinus1Year
Current Tax Year	369203443	CurrentTaxYear
Total	1733567506	Total

Field	Value	IRS element (for citing)
Public Support Total170	1733567506	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	14577277	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	21557624	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	17490065	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	24718143	CurrentTaxYearMinus1Year
Current Tax Year	13942558	CurrentTaxYear
Total	92285667	Total

Net UBI NetUBI

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	990242	CurrentTaxYearMinus4Years
Total	990242	Total

Field	Value	IRS element (for citing)
Total Support	1826843415	TotalSupport
Gross Receipts From Admissions Etc	238056259	GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage170	0.94890	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.94620	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Total Direct Lobbying TotalDirectLobbying

Field	Value	IRS element (for citing)
Filing Organizations Totals	140528	FilingOrganizationsTotals

Total Lobbying Expenditures TotalLobbyingExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	140528	FilingOrganizationsTotals

Other Exempt Purpose Expenditures OtherExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	437255261	FilingOrganizationsTotals

Total Exempt Purpose Expenditures TotalExemptPurposeExpenditures

Field	Value	IRS element (for citing)
Filing Organizations Totals	437395789	FilingOrganizationsTotals

Lobbying Nontaxable LobbyingNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	1000000	FilingOrganizationsTotals

Grassroots Nontaxable GrassrootsNontaxableAmount

Field	Value	IRS element (for citing)
Filing Organizations Totals	250000	FilingOrganizationsTotals

Tot Lobbying Grassroot Minus Non Tx TotLobbyingGrassrootMinusNonTx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Tot Lobby Expend Mns Lobbying Nontx TotLobbyExpendMnsLobbyingNontx

Field	Value	IRS element (for citing)
Filing Organizations Totals	0	FilingOrganizationsTotals

Lobbying Nontaxable Amount2 LobbyingNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	1000000	CurrentYearMinus3
Current Year Minus2	1000000	CurrentYearMinus2
Current Year Minus1	1000000	CurrentYearMinus1
Current Year	1000000	CurrentYear
Total	4000000	Total

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmount

Total Lobbying Expenditures2 TotalLobbyingExpenditures2

Field	Value	IRS element (for citing)
Current Year Minus3	106714	CurrentYearMinus3
Current Year Minus2	112213	CurrentYearMinus2
Current Year Minus1	118859	CurrentYearMinus1
Current Year	140528	CurrentYear
Total	478314	Total

Grassroots Nontaxable Amount2 GrassrootsNontaxableAmount2

Field	Value	IRS element (for citing)
Current Year Minus3	250000	CurrentYearMinus3
Current Year Minus2	250000	CurrentYearMinus2
Current Year Minus1	250000	CurrentYearMinus1
Current Year	250000	CurrentYear
Total	1000000	Total

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmount

Grassroots Lobbying Expenditures GrassrootsLobbyingExpenditures

Field	Value	IRS element (for citing)
Current Year Minus3	0	CurrentYearMinus3
Current Year Minus2	0	CurrentYearMinus2
Current Year Minus1	0	CurrentYearMinus1
Current Year	0	CurrentYear

Schedule D IRS990ScheduleD

Art Public Exhibition Amts ArtPublicExhibitionAmts

Field	Value	IRS element (for citing)
Assets In Part X	732646	AssetsInPartX

Field	Value	IRS element (for citing)
Collect Used For Public Exhibition	X	CollectUsedForPublicExhibition

Collection Used For Other CollectionUsedForOther

Field	Value	IRS element (for citing)
Collection Used For Other Purposes	X	CollectionUsedForOtherPurposes
Description Of Other Purposes	DONOR RESTRICTION	DescriptionOfOtherPurposes

Field	Value	IRS element (for citing)
Solicited Assets For Sale	0	SolicitedAssetsForSale

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	94229707	BeginningOfYearBalance
Contributions	27184000	Contributions
Investment Earnings Or Losses	-2276000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	1225000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	117912707	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	82001707	BeginningOfYearBalance
Contributions	14234000	Contributions
Investment Earnings Or Losses	14988000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	16994000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	94229707	EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	75830000	BeginningOfYearBalance
Contributions	5559524	Contributions
Investment Earnings Or Losses	7831043	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	7218860	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	82001707	EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

Field	Value	IRS element (for citing)
Beginning Of Year Balance	100751000	BeginningOfYearBalance
Contributions	4053000	Contributions
Investment Earnings Or Losses	-18913000	InvestmentEarningsOrLosses
Grants Or Scholarships	0	GrantsOrScholarships
Other Expenditures	10061000	OtherExpenditures
Administrative Expenses	0	AdministrativeExpenses
End Of Year Balance	75830000	EndOfYearBalance

Field	Value	IRS element (for citing)
Board Designated EOY Balance	0.75000	BoardDesignatedEOYBalance
Permanent Endowment EOY Balance	0.22000	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.03000	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	0	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	0	EndowmentsHeldByRelatedOrgs

Land Land

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	52389138	OtherCostOrOtherBasis
Book Value	52389138	BookValue

Buildings Buildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	380208685	OtherCostOrOtherBasis
Depreciation	190547015	Depreciation
Book Value	189661670	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	172995992	OtherCostOrOtherBasis
Depreciation	134368021	Depreciation
Book Value	38627971	BookValue

Other Land Buildings OtherLandBuildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	75401379	OtherCostOrOtherBasis
Book Value	75401379	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	356080158	TotalOfBookValueLandBuildings

Other Securities OtherSecurities (6 entries)

DescriptionDescription	Book ValueBookValue	Method Of ValuationMethodOfValuation
MORTGAGE-BACKED SECURITIES	1841379	C
COLLATERIZED MORTGAGE OBLIGATIONS	350914	C
ASSET BACKED SECURITIES	366519	C
HEDGE FUNDS	27660575	C
LIMITED PARTNERSHIPS	24441227	C
IKARIA STOCK	7879349	C

Field	Value	IRS element (for citing)
Total Of Book Value Securities	62539963	TotalOfBookValueSecurities

Investments Program Related InvestmentsProgramRelated

Field	Value	IRS element (for citing)
Description	INVESTMENT IN SEATTLE CANCER CARE ALLIANCE	Description
Book Value	77786370	BookValue
Method Of Valuation	C	MethodOfValuation

Field	Value	IRS element (for citing)
Total Of Book Value Program Related	77786370	TotalOfBookValueProgramRelated

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	DEFERRED CREDIT ON CASH FLOW HEDGES	Description
Amount	$40,196,262	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	40196262	TotalOfAmounts

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (2 entries)

Return ReferenceReturnReference	ExplanationExplanation	IdentifierIdentifier
PART III, LINE 4:	IN JANUARY 2010, THE QTIP TRUST OF THE 1993 KULLMAN FAMILY TRUST DONATED TO THE CENTER A COLLECTION OF FORTY BLACK AND WHITE PHOTOGRAPHS WHICH HAD AN APPRAISED VALUE OF $710,646 AT THE TIME OF THE DONATION. THE ARTWORK DONATION AGREEMENT REQUIRES THE CENTER TO DISPLAY THE ARTWORK AS A COLLECTION AT ITS MAIN CAMPUS IN SEATTLE, WASHINGTON FOR AT LEAST TWENTY YEARS. THE ARTWORK DONATION AGREEMENT STATES THAT "THE CENTER SHALL HAVE THE RIGHT TO USE AND DISPLAY THE ARTWORK IN THE MANNER THAT BEST SERVES THE INTEREST OF THE CENTER." AT THE END OF THE REQUIRED TWENTY YEAR DISPLAY PERIOD, THE CENTER WILL DETERMINE IF OPPORTUNITIES EXIST THAT MAY ALLOW THE VALUE OF THE DONATED ARTWORK TO FUND THE CENTER'S RESEARCH.
PART V, LINE 4:	THE CENTER'S SPENDING POLICY FOR ENDOWMENT FUNDS IS TO APPROPRIATE FOR DISTRIBUTION EACH YEAR 5% OF THE ENDOWMENT FUND'S AVERAGE FAIR VALUE OVER THE PRIOR THREE YEARS, PROVIDED THAT THE FAIR VALUE OF THE ENDOWMENT FUND EXCEEDS THE CORPUS. FOR A PORTION OF THE CENTER'S BOARD-DESIGNATED INVESTMENTS, THE CENTER DOES NOT APPROPRIATE FOR DISTRIBUTION ANY AMOUNT OF INVESTMENT RETURN AS ALL OF THE RETURN EARNED IS HELD TO GROW THE FUND FOR FUTURE REPAYMENT OF LONG-TERM DEBT. FOR THE REMAINING BOARD DESIGNATED INVESTMENTS, THE CENTER MAKES ALL INVESTMENT RETURN AVAILABLE FOR EXPENDITURE ON PROGRAMMATIC INITIATIVES. IN ESTABLISHING THESE POLICIES, THE CENTER CONSIDERED THE LONG-TERM EXPECTED RETURNS ON ITS ENDOWMENT AND BOARD-DESIGNATED INVESTMENTS.	DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	1	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (13 entries)

RegionRegion	Type Of Activities ConductedTypeOfActivitiesConducted	Total ExpendituresTotalExpenditures	Specific Services ProvidedSpecificServicesProvided
CENTRAL AMERICA AND THE CARIBBEAN	GRANTS TO RECIPIENTS LOCATED IN THE REGION	429000
EAST ASIA AND THE PACIFIC	GRANTS TO RECIPIENTS LOCATED IN THE REGION	747000
EUROPE (INCLUDING ICELAND & GREENLAND)	GRANTS TO RECIPIENTS LOCATED IN THE REGION	1394000
MIDDLE EAST AND NORTH AFRICA	GRANTS TO RECIPIENTS LOCATED IN THE REGION	10000
NORTH AMERICA	GRANTS TO RECIPIENTS LOCATED IN THE REGION	1424000
RUSSIA & THE NEWLY INDEPENDENT STATES	GRANTS TO RECIPIENTS LOCATED IN THE REGION	9000
SOUTH AMERICA	GRANTS TO RECIPIENTS LOCATED IN THE REGION	520000
SOUTH ASIA	GRANTS TO RECIPIENTS LOCATED IN THE REGION	18000
SUB-SAHARAN AFRICA	GRANTS TO RECIPIENTS LOCATED IN THE REGION	2920000
EAST ASIA AND THE PACIFIC -	PROGRAM SERVICES	38000	RESEARCH SERVICES
EUROPE (INCLUDING ICELAND & GREENLAND) -	PROGRAM SERVICES	352000	RESEARCH SERVICES
NORTH AMERICA - CANADA AND MEXICO, BUT	PROGRAM SERVICES	714000	RESEARCH SERVICES
SUB-SAHARAN AFRICA - ANGOLA,	PROGRAM SERVICES	705000	RESEARCH SERVICES

Field	Value	IRS element (for citing)
Subtotal Number Of Offices	0	SubtotalNumberOfOffices
Subtotal Number Of Employees	0	SubtotalNumberOfEmployees
Cont Number Of Offices	0	ContNumberOfOffices
Cont Number Of Employees	0	ContNumberOfEmployees
Total Number Of Offices	0	TotalNumberOfOffices
Total Number Of Employees	0	TotalNumberOfEmployees
Subtotal Amount Spent	4551000	SubtotalAmountSpent
Cont Amount Spent	4729000	ContAmountSpent
Total Amount Spent	9280000	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (33 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement
SOUTH AMERICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	369130	WIRE
SUB-SAHARAN AFRICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	396882	WIRE
NORTH AMERICA	THE STATISTICAL AND COMPUTATIONAL ANALYSIS OF FLOW CYTOM	81421	CHECK
NORTH AMERICA	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: MICRO	40481	CHECK
EUROPE (INCLUDING ICELAND & GREENLAND)	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	339991	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK	200324	WIRE
SUB-SAHARAN AFRICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	815852	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	MODELING PROSTATE CANCER CONTROL: PREVENTION, SCREENING,	259665	WIRE
SOUTH AMERICA	HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMIS	27728	WIRE
SOUTH AMERICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	29268	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME	95601	WIRE
SOUTH AMERICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	5213	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR	252929	WIRE
CENTRAL AMERICA AND THE CARIBBEAN	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	326838	WIRE
NORTH AMERICA	BHGI INTERNATIONAL LEARNING LABORATORIES	75000	WIRE
NORTH AMERICA	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR	273687	CHECK
EAST ASIA AND THE PACIFIC	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	689327	WIRE
NORTH AMERICA	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L	24456	CHECK
SOUTH AMERICA	DYNAMICS OF GRADIENT SENSING IN SINGLE CELLS	67508	WIRE
CENTRAL AMERICA AND THE CARIBBEAN	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	102246	WIRE
NORTH AMERICA	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN	159116	CHECK
NORTH AMERICA	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA	55210	CHECK
NORTH AMERICA	THE GENETICS OF PARALLEL REPRODUCTIVE ISOLATION IN STICK	217836	CHECK
SUB-SAHARAN AFRICA	HVTN LABORATORY PROGRAM	232287	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	IMMUNOBIOLOGY OF TOLERANCE FAHCT	16000	WIRE
SUB-SAHARAN AFRICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	13500	WIRE
EUROPE (INCLUDING ICELAND & GREENLAND)	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI	18115	WIRE
SUB-SAHARAN AFRICA	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL	7842	WIRE
NORTH AMERICA	HVTN LABORATORY PROGRAM	163992	CHECK
SUB-SAHARAN AFRICA	EARLY AND REINFECTION IN HIGH RISK WOMEN	29146	WIRE
NORTH AMERICA	HVTN LABORATORY PROGRAM	6359	CHECK
NORTH AMERICA	WASHINGTON VACCINE ALLIANCE	122527	CHECK
SUB-SAHARAN AFRICA	HVTN LABORATORY PROGRAM	1226344	WIRE

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	1	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	33	TotalNumberOfOtherOrgs
Transfer To Foreign Corp	1	TransferToForeignCorp
Interest In Foreign Trust	0	InterestInForeignTrust
Own Foreign Corp	1	OwnForeignCorp
Passive Foreign Invest Co	0	PassiveForeignInvestCo
Foreign Partnership	0	ForeignPartnership
Boycott Countries	0	BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV (2 entries)

IdentifierIdentifier

ExplanationExplanation

PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:

SCHEDULE F, PART I, LINE 2: ONCE THE NOTICE OF AWARD HAS BEEN RECEIVED AND THE CENTER PROJECT ID ACTIVATED, THE SUBAWARD CAN BE SET UP. THE STRUCTURE OF THE SUBAWARD WILL DEPEND ON HOW THE PRIME IS SET UP. GENERALLY AT THE CENTER, A NEW PO IS REQUISITIONED FOR EACH SUBAWARD FOR EACH YEAR OF A PROJECT. THIS ALLOWS THE RESEARCH COORDINATOR (RC) TO CLOSELY MONITOR SUBAWARD INVOICES AND ENCUMBRANCES. FOR OUR SUBRECIPIENTS, IT MEANS A SEPARATE BUDGET ID AND FINAL INVOICE EACH YEAR. CARRYOVER BETWEEN YEARS IS NOT AUTOMATIC. THERE ARE 5 PRIMARY STEPS: 1) STEP ONE IS WITHIN OSR. THE GRANT SPECIALIST NOTIFIES THE CONTRACT SPECIALIST THAT A GRANT WHICH INCLUDES A SUBAWARD HAS BEEN FUNDED AND PROVIDES TO THE CONTRACT SPECIALIST A COPY OF THE AWARD, THE SIGNED SUBAWARD APPLICATION (IF AVAILABLE) AND ANY SPECIAL INSTRUCTIONS. A SIGNED SUBAWARD APPLICATION IS IMPORTANT BECAUSE IT SHOWS THAT THE SUBRECIPIENT ORGANIZATION HAS REVIEWED AND APPROVED THE BUDGET AND SCOPE OF WORK. 2) THE RC SENDS THE CONTRACT SPECIALIST A SUBCONTRACT ACUISITION FORM (SAF). THIS FORM PROVIDES AUTHORIZATION FOR THE CONTRACT SPECIALIST TO ISSUE THE SUBAWARD. INCLUDED IN THIS FORM IS A SCOPE OF WORK, BUDGET AND PERTINENT SUBRECIPIENT INFORMATION. IT IS NECESSARY TO PROVIDE THE SCOPE OF WORK AND BUDGET ON THE SAF AS THESE TIMES MAY HAVE CHANGED FROM WHAT WAS ORIGINALLY SUBMITTED IN THE SUBAWARD APPLICATION. 3) THE CONTRACT SPECIALIST REQUISITIONS THE SUBAWARD PO, WHICH THE RC MUST APPROVE. AN EMAIL IS SENT TO THE RC NOTIFYING THEM THAT THE REQUISITION IS PENDING AND REQUIRES APPROVAL. BECAUSE OSR DOES NOT HAVE FUNDS COMMITMENT AUTHORITY THE RC IS REQUIRED TO APPROVE ALL REQUISITIONS. 4) OSR COLLECTS INFORMATION REQUIRED TO CORRECTLY SET UP THE SUBAWARD. THESE ITEMS INCLUDE IRO AND IACUC APPROVAL DATES, CONFIRMATION OF SUBAWARD F&A RATES AND A-133 AUDIT REPORTS, REVIEW OF PRIME SPECIAL TERMS AND CONDITIONS TO DETERMINE FLOW-DOWN, CONFIRMATION THAT THE SUBRECIPIENT IS NOT DEBARRED, AND OTHER SIMILAR REGULATORY AND ADMINISTRATIVE REQUIREMENTS. WHILE MUCH OF THIS INFORMATION IS COLLECTED BY OSR, THE RC MAY, IN ADDITION TO COMPLETING THE SAF, BE ASKED TO ASSIST IN THE COLLECTION OF SOME OF THE DOCUMENTATION. 5) OSR WRITES THE SUBAWARD AGREEMENT, AND MAILS IT TO THE SUBRECIPIENT FOR SIGNATURE. SOME AGREEMENTS CAN BE SIGNED BY OSR BEFORE MAILING, WHILE OTHERS WILL BE SENT UNSIGNED. THIS IS DETERMINED BY THE CONTRACT SPECIALIST BASED ON THE TERMS OF AWARD AND STATUS OF ADMINISTRATIVE AND REGULATORY REQUIREMENTS. A COPY OF THE INITIAL SUBAWARD IS SENT THE RC. ONCE THE SUBAWARD HAS BEEN FULLY SIGNED, A COPY IS SENT TO THE RC FOR THEIR FILES. NO INVOICES SHOULD BE APPROVED BY THE RC UNTIL THEY HAVE RECEIVED A FULLY EXECUTED AGREEMENT.

METHOD USED TO ACCCOUNT FOR EXPENDITURES:

SCHEDULE F, PART I, LINE 3: THE ACCRUAL METHOD WAS USED IN ACCOUNTING FOR EXPENDITURES IN PARTS I AND II.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
Phone Solicitations	X	PhoneSolicitations
In Person Solicitations	X	InPersonSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Special Fundraising Events	X	SpecialFundraisingEvents
Agreement Ref Fundraising	1	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation (2 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	ActivityActivity	Fundraiser Control Of FundsFundraiserControlOfFunds	Gross ReceiptsGrossReceipts	Amount Retained By ContractorAmountRetainedByContractor	Net To OrganizationNetToOrganization
SEE PART IV
P O BOX 3257	PORTLAND	OR	97208	DIRECT MAIL	0	629059	64006	565053
SEE PART IV
1511 ROUTE 22 SUITE C-25	BREWSTER	NY	10509	TELEMARKETING	0	22065	19070	2995

Field	Value	IRS element (for citing)
Total Gross Receipts	651124	TotalGrossReceipts
Total Retained By Contractors	83076	TotalRetainedByContractors
Total Net To Organization	568048	TotalNetToOrganization
Licensed States	AK	LicensedStates
Licensed States	AL	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	WV	LicensedStates
Licensed States	WI	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	VA	LicensedStates

Events Information EventsInformation

Field	Value	IRS element (for citing)
Name Of Event1	HOLIDAY AUCTION	NameOfEvent1
Gross Receipts Event1	3390624	GrossReceiptsEvent1
Charitable Contributions Event1	2883712	CharitableContributionsEvent1
Gross Revenue Event1	506912	GrossRevenueEvent1
Food And Beverage Event1	172910	FoodAndBeverageEvent1
Entertainment Event1	1924	EntertainmentEvent1
Other Direct Expenses Event1	598276	OtherDirectExpensesEvent1
Name Of Event2	CLIMB FOR CANCER	NameOfEvent2
Gross Receipts Event2	608034	GrossReceiptsEvent2
Charitable Contributions Event2	607234	CharitableContributionsEvent2
Gross Revenue Event2	800	GrossRevenueEvent2
Other Direct Expenses Event2	320657	OtherDirectExpensesEvent2
Total Number Of Other Events	6	TotalNumberOfOtherEvents
Gross Receipts Other Events	1363203	GrossReceiptsOtherEvents
Charitable Contrib Other Events	1098938	CharitableContribOtherEvents
Gross Revenue Other Events	264265	GrossRevenueOtherEvents
Food And Beverage Other Events	51228	FoodAndBeverageOtherEvents
Entertainment Other Events	30000	EntertainmentOtherEvents
Other Direct Expenses Other Events	200264	OtherDirectExpensesOtherEvents
Gross Receipts Total	5361861	GrossReceiptsTotal
Charitable Contributions Total	4589884	CharitableContributionsTotal
Gross Revenue Total Events	771977	GrossRevenueTotalEvents
Food And Beverage Total Events	224138	FoodAndBeverageTotalEvents
Entertainment Total Events	31924	EntertainmentTotalEvents
Other Direct Expenses Total Events	1119197	OtherDirectExpensesTotalEvents
Direct Expense Summary Events	1375259	DirectExpenseSummaryEvents
Net Income Summary	-603282	NetIncomeSummary

Gaming Information GamingInformation

Field	Value	IRS element (for citing)
Gross Revenue Other Gaming	82055	GrossRevenueOtherGaming
Non Cash Prizes Other Gaming	13500	NonCashPrizesOtherGaming
Volunteer Labor Other Gaming	1	VolunteerLaborOtherGaming
Volunteer Labor Prcnt Other Gaming	0.95000	VolunteerLaborPrcntOtherGaming
Gross Revenue Total Gaming	82055	GrossRevenueTotalGaming
Non Cash Prizes Total Gaming	13500	NonCashPrizesTotalGaming
Direct Expense Summary Gaming	13500	DirectExpenseSummaryGaming
Net Gaming Income Summary	68555	NetGamingIncomeSummary

Field	Value	IRS element (for citing)
States Where Gaming Conducted	WA	StatesWhereGamingConducted
Licensed	1	Licensed
License Suspended Etc	0	LicenseSuspendedEtc
Gaming With Nonmembers	1	GamingWithNonmembers
Member Of Other Entity	0	MemberOfOtherEntity
Percentage Of Gaming Own Facility	0.00000	PercentageOfGamingOwnFacility
Percentage Of Gaming Othr Facility	1.00000	PercentageOfGamingOthrFacility

Name Of Gaming Rec Keeper Bus NameOfGamingRecKeeperBus

Field	Value	IRS element (for citing)
Business Name Line1	ACCOUNTING DEPARTMENT	BusinessNameLine1

Address Of Gaming Rec Keeper US AddressOfGamingRecKeeperUS

Field	Value	IRS element (for citing)
Address Line1	1100 FAIRVIEW AVENUE NORTH	AddressLine1
City	SEATTLE	City
State	WA	State
ZIP Code	98109	ZIPCode

Field	Value	IRS element (for citing)
Contract With3rd Party For Gam Rev	0	ContractWith3rdPartyForGamRev
Gaming Manager Name Person	KRISTEN SCHERRER	GamingManagerNamePerson
Gaming Manager Compensation	5000	GamingManagerCompensation
Gaming Manager Services Provided	PLANNING RAFFLE, PROCURING PRIZES, AND COORDINATING WITH VOLUNTEERS.	GamingManagerServicesProvided
Gaming Manager Is Employee	X	GamingManagerIsEmployee
Charitable Distrib Required	0	CharitableDistribRequired
Amount Distributed	0	AmountDistributed

Form990 Schedule G Part IV Form990ScheduleGPartIV

Field	Value	IRS element (for citing)
Return Reference	SCHEDULE G, PART I, LINE 2B, LIST OF TEN HIGHEST PAID FUNDRAISERS:	ReturnReference
Explanation	(I) NAME OF FUNDRAISER: LEWIS KENNEDY ASSOCIATES INC (I) ADDRESS OF FUNDRAISER: PO BOX 3257 PORTLAND, OR 97208 (I) NAME OF FUNDRAISER: HARRIS CONNECT GROUP HOLDINGS LLC (I) ADDRESS OF FUNDRAISER: 1511 ROUTE 22, SUITE C-25 BREWSTER, NY 10509	Explanation

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	1	RecordsMaintained

Recipient Table RecipientTable (357 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant
ADMINISTRATORS OF THE TULANE
800 E COMMERCE RD SUITE 203	HARAHAN	LA	70123	720423889	501(C)(3)	31005	HVTN LABORATORY PROGRAM
AIDS RESEARCH ALLIANCE OF AMERICA
1400 S GRAND AVE SUITE 701	LOS ANGELES	CA	90015	954264845	501(C)(3)	783190	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
ALERE WELLBEING INC
P O BOX 402617	ATLANTA	GA	303842617	200231080		33760	IMPROVING SMOKING CESSATION QUITLINES
BATTELLE MEMORIAL INSTITUTE
1100 DEXTER AVE NORTH SUITE 400	SEATTLE	WA	981093598	314379427	501(C)(3)	81626	IMPROVING EARLY DETECTION OF BREAST CANCER
BATTELLE MEMORIAL INSTITUTE
1100 DEXTER AVE NORTH SUITE 400	SEATTLE	WA	981093598	314379427	501(C)(3)	9390	RADIATION DOSE-DEPENDENT INTERVENTIONS
BATTELLE MEMORIAL INSTITUTE
PACIFIC NW NATIONAL LABORATORY	RICHLAND	WA	99352	314379427	501(C)(3)	2956	TARGETED RADIOTHERAPY WITH 90Y-BC8 MONOCLONAL ANTIBODY
BATTELLE MEMORIAL INSTITUTE
1100 DEXTER AVE NORTH SUITE 400	SEATTLE	WA	981093598	314379427	501(C)(3)	45175	THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
BAYLOR COLLEGE OF MEDICINE
ONE BAYLOR PLAZA ROOM BCM280	HOUSTON	TX	77030	741613878	501(C)(3)	324712	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
BAYLOR COLLEGE OF MEDICINE
P O BOX 201361	HOUSTON	TX	772161361	741613878	501(C)(3)	20071	PEDIATRIC GLIOBLASTOMA THERAPIES
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	910103012	953432210	501(C)(3)	35819	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTIBILITY
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	910103010	953432210	501(C)(3)	8455	CTRIP: NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITOR
BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE
1500 E DUARTE RD	DUARTE	CA	910103012	953432210	501(C)(3)	90814	TARGETED MODIFICATION OF HOST AND PROVIRAL DNA
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVENUE	SEATTLE	WA	98101	910653422	501(C)(3)	1724	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVENUE	SEATTLE	WA	98101	910653422	501(C)(3)	33001	HEMATOPOIETIC CELL TRANSPLANTATION AND IRON OVERLOAD
BENAROYA RESEARCH INSTITUTE
1201 NINTH AVENUE	SEATTLE	WA	98101	910653422	501(C)(3)	79854	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUE	BOSTON	MA	02215	042103881	501(C)(3)	16455	HVTN LABORATORY PROGRAM
BOARD OF TRUSTEES OF THE LELAND STANFORD JR UNIVERSITY
P O BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	50793	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
BOARD OF TRUSTEES OF THE LELAND STANFORD JR UNIVERSITY
P O BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	33279	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
BOARD OF TRUSTEES OF THE LELAND STANFORD JR UNIVERSITY
P O BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	35336	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
BOARD OF TRUSTEES OF THE LELAND STANFORD JR UNIVERSITY
P O BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	47979	OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH
BOARD OF TRUSTEES OF THE LELAND STANFORD JR UNIVERSITY
P O BOX 44253	SAN FRANCISCO	CA	941444253	941156365	501(C)(3)	126864	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS
P O BOX 20787	SPRINGFIELD	IL	627080787	376000511	UNIVERSITY	52485	HVTN LABORATORY PROGRAM
BOARD OF TRUSTEES UNIVERSITY OF ILLINOIS
P O BOX 20787	SPRINGFIELD	IL	627080787	376000511	UNIVERSITY	896343	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	69693	BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	38918	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	70605	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	179457	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	656915	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	914889	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
BRIGHAM AND WOMENS HOSPITAL INC
FINANCE P O BOX 3887	BOSTON	MA	022413887	402312909	501(C)(3)	47615	OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	14975	BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	359672	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	562474	IMPROVING EARLY DETECTION OF BREAST CANCER
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	945127	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C
BROAD INSTITUTE INC
7 CAMBRIDGE CENTER	CAMBRIDGE	MA	02142	263428781	501(C)(3)	53481	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM
CALIFORNIA RURAL INDIAN HEALTH BOARD INC
4400 AUBURN BLVD 2ND FLOOR	SACRAMENTO	CA	95841	237052541	501(C)(3)	25832	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE SUITE 1900	SEATTLE	WA	981011468	911828539	501(C)(3)	225590	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
CANCER RESEARCH AND BIOSTATISTICS
1730 MINOR AVENUE SUITE 1900	SEATTLE	WA	981011468	911828539	501(C)(3)	2983728	SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE	CLEVELAND	OH	441067037	341018992	501(C)(3)	480394	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
CASE WESTERN RESERVE UNIVERSITY
10900 EUCLID AVENUE	CLEVELAND	OH	441067037	341018992	501(C)(3)	313267	IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS
CEDARS SINAI MEDICAL CENTER
6500 WILSHIRE BLVD SUITE 1150	LOS ANGELES	CA	90048	951644600	501(C)(3)	8254	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION
CEDARS SINAI MEDICAL CENTER
6500 WILSHIRE BLVD SUITE 1150	LOS ANGELES	CA	90048	951644600	501(C)(3)	173432	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
CEDARS SINAI MEDICAL CENTER
6500 WILSHIRE BLVD SUITE 1150	LOS ANGELES	CA	90048	951644600	501(C)(3)	3179	VITAMIN D AND PROSTATE CANCER: BIOMARKERS AND GENETIC
CENTER FOR MEDICAL TECHNOLOGY POLICY
401 EAST PRATT ST SUITE 631	BALTIMORE	MD	21202	261409553	501(C)(3)	144998	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUE	CINCINNATI	OH	452293039	310833936	501(C)(3)	41704	DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIES
CITY AND COUNTY OF SAN FRANCISCO
1380 HOWARD ST RM 408	SAN FRANCISCO	CA	941032614	946000417	CITY-CNT OF SF	304913	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
CITY OF PHILADELPHIA
1401 JOHN KENNEDY BLVD SUITE 1380	PHILADELPHIA	PA	19102	236003047	CITY OF PHILADELPHIA	229309	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
CLINICAL ALLIANCE FOR RESEARCH AND EDUCATION
3289 WOODBURN RD SUITE 250	ANNANDALE	VA	22003	202651141		221568	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
COMSYS INFO TECHNOLOGY SERVICES LLC
P O BOX 905378	CHARLOTTE	NC	282905378	751300240		347240	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INITIATIVE
CONCEPT SYSTEMS INCORPORATED
136 EAST STATE ST	ITHACA	NY	14850	161473796		72342	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
CORNELL UNIVERSITY
P O BOX 22	ITHACA	NY	148510022	150532082	501(C)(3)	63361	TOWARDS A MODEL OF FANCONI ANEMIA
DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	5147	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
DANA FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BOSTON	MA	02215	042263040	501(C)(3)	60278	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
DISTRICT OF COLUMBIA GOV DC TREASURY
899 NORTH CAPITOL NE	WASHINGTON	DC	20002	536001131	DISTRICT OF COLUMBIA	416535	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
DUKE UNIVERSITY
2200 W MAIN ST SUITE 300	DURHAM	NC	277054677	560532129	501(C)(3)	2148189	HVTN LABORATORY PROGRAM
DUKE UNIVERSITY
2200 W MAIN ST SUITE 300	DURHAM	NC	277054677	560532129	501(C)(3)	61023	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
EMORY UNIVERSITY
1599 CLIFTON RD NE	ATLANTA	GA	303224250	580566256	501(C)(3)	169839	CONTAINING BIOTERRORISM AND EMERGING INFECTIOUS DISEASES
EMORY UNIVERSITY
1599 CLIFTON RD NE	ATLANTA	GA	303224250	580566256	501(C)(3)	285039	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY
EMORY UNIVERSITY
1599 CLIFTON RD NE	ATLANTA	GA	303224250	580566256	501(C)(3)	965927	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
EXAMINATION MANAGEMENT SERVICES INC
P O BOX 202669	DALLAS	TX	752302669	751444139		156144	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INITIATIVE
FENWAY COMMUNITY HEALTH
1340 BOYLSTON ST FINANCE 9TH FLOOR	BOSTON	MA	02215	042510564	501(C)(3)	478600	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
FENWAY COMMUNITY HEALTH
1340 BOYLSTON ST FINANCE 9TH FLOOR	BOSTON	MA	02215	042510564	501(C)(3)	12703	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
FISHER BIOSERVICES
P O BOX 418395	BOSTON	MA	022418395	541348241		754114	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INITIATIVE
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027	BOSTON	MA	022983027	161056814	501(C)(3)	104762	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027	BOSTON	MA	022983027	161056814	501(C)(3)	95803	HVTN LABORATORY PROGRAM
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027	BOSTON	MA	022983027	161056814	501(C)(3)	48298	HVTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027	BOSTON	MA	022983027	161056814	501(C)(3)	42142	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS
FRONTIER SCIENCE AND TECHNOLOGY
P O BOX 983027	BOSTON	MA	022983027	161056814	501(C)(3)	44080	RAPID SCALEUP OF HIV/AIDS CARE AND TREATMENT SERVICES
GENERAL HOSPITAL CORPORATION
P O BOX 3829	BOSTON	MA	022413829	042697983	501(C)(3)	202240	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS
GENERAL HOSPITAL CORPORATION
P O BOX 3829	BOSTON	MA	022413829	042697983	501(C)(3)	45054	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS
GENERAL HOSPITAL CORPORATION
P O BOX 414876	BOSTON	MA	022414876	042697983	501(C)(3)	165456	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
GROUP HEALTH COOPERATIVE
P O BOX 34587	SEATTLE	WA	981249990	910511770	501(C)(3)	381746	ACCEPTANCE AND COMMITMENT THERAPY FOR SMOKING CESSATI
GROUP HEALTH COOPERATIVE
P O BOX 34587	SEATTLE	WA	981249990	910511770	501(C)(3)	820480	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
GROUP HEALTH COOPERATIVE
P O BOX 34587	SEATTLE	WA	981249990	910511770	501(C)(3)	6876	PREVENTION OF OVARIAN CANCER IN WOMEN
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
12902 MAGNOLIA DRIVE	TAMPA	FL	33612	593238634	501(C)(3)	30704	AFFINITY BASED STRATEGIES TO FAST TRACK DEVELOPMENT OF C
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
12902 MAGNOLIA DRIVE	TAMPA	FL	33612	593238634	501(C)(3)	51800	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
12902 MAGNOLIA DRIVE	TAMPA	FL	33612	593238634	501(C)(3)	20488	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
HEKTOEN INSTITUTE FOR MED RESEARCH LLC
2240 W OGDEN AVE	CHICAGO	IL	606129982	362244897	501(C)(3)	133560	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
HEMATOLOGICS INC
P O BOX 24712	SEATTLE	WA	98124	911685196		42400	BRIDGE FUNDING: MOLECULAR ASSESSMENT OF MINIMAL RISK DIS
INDIANA UNIVERSITY
P O BOX 66057	INDIANAPOLIS	IN	462666057	356001673	UNIVERSITY	326018	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
INFECTIOUS DISEASE CNSLTNTS MD PA DBA
1701 N MILLS AVE	ORLANDO	FL	32803	591634257		1418895	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DR	CHICAGO	IL	60693	520595110	501(C)(3)	12903	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DR	CHICAGO	IL	60693	520595110	501(C)(3)	80474	BIOCONDUCTOR: AN OPEN COMPUTING RESOURCE FOR GENOMICS
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DR	CHICAGO	IL	60693	520595110	501(C)(3)	9753	GENETIC PROGRESSION OF PANCREATIC MUCINOUS CYSTIC NEOPLA
JOHNS HOPKINS UNIVERSITY
12529 COLLECTIONS CENTER DR	CHICAGO	IL	60693	520595110	501(C)(3)	37195	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
KAISER FOUNDATION HOSPITALS
1800 HARRISON ST 16TH FLOOR	OAKLAND	CA	946123433	941105628	501(C)(3)	18005	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
KAISER FOUNDATION HOSPITALS
1800 HARRISON ST 16TH FLOOR	OAKLAND	CA	946123433	941105628	501(C)(3)	354824	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INITIATIVE
KAISER FOUNDATION HOSPITALS
1800 HARRISON ST 16TH FLOOR	OAKLAND	CA	946123433	941105628	501(C)(3)	637986	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
KAISER FOUNDATION HOSPITALS
1800 HARRISON ST 16TH FLOOR	OAKLAND	CA	946123433	941105628	501(C)(3)	7873	PARTNERSHIP FOR THE ADVANCEMENT OF CANCER RESEARCH: NMS
KAISER FOUNDATION HOSPITALS
1800 HARRISON ST 16TH FLOOR	OAKLAND	CA	946123433	941105628	501(C)(3)	49911	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES
LABKEY CORPORATION
2226 EASTLAKE AVE E 101	SEATTLE	WA	98102	208266728	501(C)(3)	165824	CROSS-SPECIES HIV IMMUNOLOGY STATISTICS AND DATA CENTER
LABKEY CORPORATION
2226 EASTLAKE AVE E 101	SEATTLE	WA	98102	208266728	501(C)(3)	368213	HVTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
LOUISIANA STATE UNIVERSITY HEALTH
433 BOLIVAR ST	NEW ORLEANS	LA	701122223	726087770	UNIVERSITY	44528	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
77 MASSACHUSETTS AVENUE	CAMBRIDGE	MA	02139	042103594	501(C)(3)	222708	HVTN LABORATORY PROGRAM
MAYO CLINIC ROCHESTER
P O BOX 4008	ROCHESTER	MN	559034008	416011702	501(C)(3)	64014	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	MILWAUKEE	WI	532260509	390806261	501(C)(3)	33058	HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	MILWAUKEE	WI	532260509	390806261	501(C)(3)	4204	HEMATOPOPIETIC STEM CELL TRANSPLANTATION
MEDICAL COLLEGE OF WISCONSIN INC
8701 WATERTOWN PLANK RD	MILWAUKEE	WI	532260509	390806261	501(C)(3)	21661	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722	UNIVERSITY	12400	HVTN LABORATORY PROGRAM
MEDICAL UNIVERSITY OF SOUTH CAROLINA
19 HAGOOD AVE SUITE 303 MSC 804	CHARLESTON	SC	294258040	576000722	UNIVERSITY	11549	RADIATION DOSE-DEPENDENT INTERVENTIONS
MIRIAM HOSPITAL
593 EDDY ST	PROVIDENCE	RI	02903	050258905	501(C)(3)	182914	HVTN LABORATORY PROGRAM
MIRIAM HOSPITAL
593 EDDY ST	PROVIDENCE	RI	02903	050258905	501(C)(3)	14823	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
MOUNT SINAI SCHOOL OF MEDICINE
ONE GUSTAVE L LEVY PLACE	NEW YORK	NY	10029	136171197	501(C)(3)	18336	A POOLED ANALYSIS OF RISK FACTORS OF SMALL INTESTINE
NATIONAL INSTITUTES OF HEALTH
10 CENTER DR CRC RM 3-330	BETHESDA	MD	20892	520858115	NATIONAL INSTITUTES	190000	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY
NATIONAL MARROW DONOR PROGRAM
P O BOX 1450	MINNEAPOLIS	MN	554858428	840865803	501(C)(3)	93607	HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION
NEW YORK BLOOD CENTER INC
1200 PROSPECT AVENUE	WESTBURY	NY	11590	131949477	501(C)(3)	1147062	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
545 FIRST AVENUE	NEW YORK	NY	10016	135562309	UNIVERSITY	80924	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
545 FIRST AVENUE	NEW YORK	NY	10016	135562309	UNIVERSITY	32543	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
NORTHEASTERN UNIVERSITY
360 HUNTINGTON AVE	BOSTON	MA	02115	041679980	501(C)(3)	170989	NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN
NORTHWEST COMMUNITIES EDUCATION CENTER
P O BOX 800	GRANGER	WA	98932	910969818	501(C)(3)	26160	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM
NORTHWEST PORTLAND AREA INDIAN
2121 SW BROADWAY STE 300	PORTLAND	OR	97201	930718154	501(C)(3)	26938	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME
NY CITY DEPT OF HLTH AND MENTAL HYGIENE
42-09 28TH ST CN 48	QUEENS	NY	111014132	136400434	501(C)(3)	488989	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	COLUMBUS	OH	432101063	316401599	501(C)(3)	19412	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	COLUMBUS	OH	432101063	316401599	501(C)(3)	41865	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS
OHIO STATE UNIVERSITY RSRCH FOUNDATION
1960 KENNY RD	COLUMBUS	OH	432101063	316401599	501(C)(3)	13343	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT ST	PORTLAND	OR	97239	931176109	UNIVERSITY	476211	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT ST	PORTLAND	OR	97239	931176109	UNIVERSITY	1110213	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT ST	PORTLAND	OR	97239	931176109	UNIVERSITY	634967	IMMUNIZATION OF ORAL MUCOSA FOR INDUCTION OF RECTAL AND
OREGON HEALTH & SCIENCE UNIVERSITY
0690 SW BANCROFT ST	PORTLAND	OR	97239	931176109	UNIVERSITY	93900	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
OREGON UNIVERSITY SYSTEM
5219 UNIVERSITY OF OREGON	EUGENE	OR	974035219	936001786	UNIVERSITY	89712	TILLING THE ZEBRAFISH GENOME: A REVERSE GENETICS APPROACH
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	180034	EPIGENOMIC PROFILING OF HISTONE TURNOVER KINETICS
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	114214	GENOME-WIDE PROFILING OF HISTONE VARIANTS IN DROSOPHILA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	42421	GENOME-WIDE PROFILINGOF HISTONE VARIANTS IN DROSOPHILA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	24502	HVTN LABORATORY PROGRAM
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
P O BOX 415649	BOSTON	MA	022415649	042103580	501(C)(3)	36535	STATISTICAL METHODS FOR PROSPECTIVE EVALUATION
PROVIDENCE HEALTH & SERVICES-OREGON
4805 NE GLISAN ST SUITE 5F40	PORTLAND	OR	97213	930386906	HOSPITAL	8880	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
PUBLIC HEALTH FOUNDATION ENTERPRISES INC
12801 CROSSROADS PARKWAY SOUTH 200	CITY OF INDUSTRY	CA	91746	952557063	501(C)(3)	1087008	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE	SEATTLE	WA	981041256	911019655	501(C)(3)	11240	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
PUGET SOUND BLOOD CENTER AND PROGRAM
921 TERRY AVENUE	SEATTLE	WA	981041256	911019655	501(C)(3)	11414	THERAPIES FOR HEMATOPOIETIC SYNDROME, BONE MARROW STROMA
REGENTS OF THE UNIV OF CALIFORNIA
ACCOUNTING OFFICE - EMF BOX 0897	SAN FRANCISCO	CA	94143	946036493	UNIVERSITY	81534	BARRETT'S ESOPHAGUS: PREDICTORS OF PROGRESSION
REGENTS OF THE UNIV OF CALIFORNIA
ACCOUNTING OFFICE - EMF BOX 0897	SAN FRANCISCO	CA	94143	946036493	UNIVERSITY	129121	MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI
REGENTS OF THE UNIV OF CALIFORNIA
ACCOUNTING OFFICE - EMF BOX 0897	SAN FRANCISCO	CA	94143	946036493	UNIVERSITY	36781	MODELING PROSTATE CANCER CONTROL: PREVENTION AND SCREENING
REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE
BIOLOGICAL SCIENCES III SUITE 1400	IRVINE	CA	926971050	952226406	UNIVERSITY	44800	EARLY AND REINFECTION IN HIGH RISK WOMEN
REGENTS OF THE UNIVERSITY OF CALIFORNIA
CASHIERS OFFICE P O BOX 989062	WEST SACRAMENTO	CA	957989062	946036494	UNIVERSITY	65865	A PROSPECTIVE STUDY OF COLORECTAL CANCER
REGENTS OF THE UNIVERSITY OF CALIFORNIA
CASHIERS OFFICE P O BOX 989062	WEST SACRAMENTO	CA	957989062	946036494	UNIVERSITY	25909	BIOMARKER DISCOVERY FOR MITOCHONDRIAL TOXICANTS
REGENTS OF THE UNIVERSITY OF CALIFORNIA
CASHIERS OFFICE P O BOX 989062	WEST SACRAMENTO	CA	957989062	946036494	UNIVERSITY	190452	BISPECIFIC ANTIBODY ENGINEERING FOR AML RIT
REGENTS OF THE UNIVERSITY OF CALIFORNIA
CASHIERS OFFICE P O BOX 989062	WEST SACRAMENTO	CA	957989062	946036494	UNIVERSITY	19446	STATISTICAL METHODS FOR INTEGRATIVE ANALYSIS OF GENOMICS
REGENTS OF THE UNIVERSITY OF MICHIGAN
24 FRANK LLOYD WRIGHT DRIVE	ANN ARBOR	MI	48106	386006309	UNIVERSITY	22955	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
REGENTS OF THE UNIVERSITY OF MICHIGAN
24 FRANK LLOYD WRIGHT DRIVE	ANN ARBOR	MI	48106	386006309	UNIVERSITY	51660	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
REGENTS OF THE UNIVERSITY OF MICHIGAN
24 FRANK LLOYD WRIGHT DRIVE	ANN ARBOR	MI	48106	386006309	UNIVERSITY	243788	MODELING PROSTATE CANCER CONTROL: PREVENTION AND SCREENING
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	748480	CORE ASSAYS MRLI - W1, W3
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	7554	CTRIP: NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITOR
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	65411	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	78656	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	99607	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	80182	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 P O BOX 1450	MINNEAPOLIS	MN	554855957	416007513	UNIVERSITY	13422	METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
REGENTS OF UNIVERSITY OF COLORADO
P O BOX 910238	DENVER	CO	802910238	846000555	UNIVERSITY	26684	CTRIP: NOTCH-MEDIATED EXPANSION OF CORD BLOOD PROGENITOR
REGENTS OF UNIVERSITY OF COLORADO
P O BOX 910238	DENVER	CO	802910238	846000555	UNIVERSITY	1046667	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
REGENTS OF UNIVERSITY OF COLORADO
P O BOX 910238	DENVER	CO	802910238	846000555	UNIVERSITY	26225	VITAMIN D AND PROSTATE CANCER: BIOMARKERS AND GENETIC VA
REGENTS UNIVERSITY OF CALIF AT LOS ANGELES
405 HILGARD AVENUE	LOS ANGELES	CA	900959000	956006143	UNIVERSITY	51116	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA
REGENTS UNIVERSITY OF CALIF AT LOS ANGELES
405 HILGARD AVENUE	LOS ANGELES	CA	900959000	956006143	UNIVERSITY	25990	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES
REGENTS UNIVERSITY OF CALIF AT LOS ANGELES
405 HILGARD AVENUE	LOS ANGELES	CA	900959000	956006143	UNIVERSITY	201670	HVTN LABORATORY PROGRAM
REGENTS UNIVERSITY OF CALIF AT LOS ANGELES
405 HILGARD AVENUE	LOS ANGELES	CA	900959000	956006143	UNIVERSITY	52112	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
REGENTS UNIVERSITY OF CALIF AT LOS ANGELES
405 HILGARD AVENUE	LOS ANGELES	CA	900959000	956006143	UNIVERSITY	72524	MARKERS OF B-CELL STIMULATION AS POTENTIAL PREDICTORS OF
RESEARCH FOUNDATION OF STATE UNIVERSITY
P O BOX 9	ALBANY	NY	122010009	141368361	501(C)(3)	26172	OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH IN
RESEARCH FOUNDATION OF STATE UNIVERSITY
P O BOX 9	ALBANY	NY	122010009	141368361	501(C)(3)	82221	POPULATION PHARMACOKINETICS / PHARMACODYNAMICS IN NONABL
RHODE ISLAND HOSPITAL
593 EDDY ST	PROVIDENCE	RI	02903	050258954	501(C)(3)	32325	HVTN LABORATORY PROGRAM
SAINT JUDE CHILDRENS RESEARCH HOSPITAL
262 DANNY THOMAS PL	MEMPHIS	TN	381480949	620646012	501(C)(3)	13511	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
SAINT LOUIS UNIVERSITY
3700 WEST PINE MALL	SAINT LOUIS	MO	63108	430654872	501(C)(3)	14976	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
SANGAMO BIOSCIENCES INC
501 CANAL BLVD SUITE A100	RICHMOND	CA	94804	680359556		441408	TARGETED MODIFICATION OF HOST AND PROVIRAL DNA TO TREAT
SEA MAR COMMUNITY HEALTH CENTER
8915 14TH AVE S	SEATTLE	WA	98108	911020139		121251	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N SUITE 500	SEATTLE	WA	981095219	910961784	501(C)(3)	350165	HARNESSING INNATE IMMUNITY TO ENHANCE IMMUNOGENICITY OF
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N SUITE 500	SEATTLE	WA	981095219	910961784	501(C)(3)	43601	N/A
SEATTLE BIOMEDICAL RESEARCH INSTITUTE
307 WESTLAKE AVE N SUITE 500	SEATTLE	WA	981095219	910961784	501(C)(3)	21176	WASHINGTON VACCINE ALLIANCE
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	4702	A COMPREHENSIVE CATALOGUE OF MOUSE DNASEI HYPERSENSITIVE
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	101896	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	231451	CONSORTIUM BIOSPECIMEN PROGRAM
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	10865	DIETARY FRUCTOSE AND LOW-GRADE INFLAMMATION
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	36145	METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	25064	PREGNANCY, MICROCHIMERISM, AND AUTOIMMUNE DISEASE
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	49570	STEM CELL TRANSPLANTATION: BASIC/CLINICAL RESEARCH
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	110227	TARGETED MODIFICATION OF HOST AND PROVIRAL DNA TO TREAT
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	271421	TARGETED THERAPY OF ALL WITH GENE-MODIFIED CENTRAL MEMOR
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	11637	TOWARDS A MODEL OF FANCONI ANEMIA
SEATTLE CHILDREN'S HOSPITAL
P O BOX 24728	SEATTLE	WA	981240728	910564748	501(C)(3)	12021	WHOLE GENOME ASSOCIATION ANALYSIS OF HEMATOPOIETIC CELL
SEATTLE INST FOR BIOMED & CLINICAL RES
1100 OLIVE WAY SUITE 940	SEATTLE	WA	98101	911452438	501(C)(3)	45251	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA
SEATTLE INST FOR BIOMED & CLINICAL RES
1100 OLIVE WAY SUITE 940	SEATTLE	WA	98101	911452438	501(C)(3)	120214	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
P O BOX 26338	NEW YORK	NY	10087	131624182	501(C)(3)	50688	GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
P O BOX 26338	NEW YORK	NY	10087	131624182	501(C)(3)	207092	HEMATOPOIETIC STEM CELL AND CORD BLOOD TRANSPLANTATION
SLOAN KETTERING INSTITUTE FOR CANCER RESEARCH
P O BOX 26338	NEW YORK	NY	10087	131624182	501(C)(3)	39736	HEMATOPOPIETIC STEM CELL TRANSPLANTATION
STATE OF FLORIDA DEPT OF HEALTH
4052 BALD CYPRESS WAY BIN B20	TALLAHASSEE	FL	323991729	593502843		17690	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORK
SUNNYSIDE COMMUNITY HOSPITAL INC
P O BOX 719	SUNNYSIDE	WA	98944	911286274	501(C)(3)	49500	PARTNERSHIP FOR A HISPANIC DIABETES PREVENTION PROGRAM
SWEDISH HEALTH SERVICES
P O BOX 94085	SEATTLE	WA	981249485	910433740	501(C)(3)	38758	BREAST AND OVARY CANCER CLINICAL VALIDATION CENTER
SWEDISH HEALTH SERVICES
P O BOX 94085	SEATTLE	WA	981249485	910433740	501(C)(3)	11000	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
SWEDISH HEALTH SERVICES
P O BOX 94085	SEATTLE	WA	981249485	910433740	501(C)(3)	2570	PREVENTION OF OVARIAN CANCER IN WOMEN PARTICIPATING
TORREY PINES INST FOR MOLECULAR STUDIES
11350 SW VILLAGE PARKWAY PORT ST	LUCIE	FL	34987	330319501	501(C)(3)	33533	IDENTIFICATION OF T CELL-DEFINED ANTIGENS IN OVARIAN CAN
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	87882	A PROSPECTIVE STUDY OF COLORECTAL CANCER
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	2457953	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	1147764	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	348262	EPIDEMIOLOGY OF PUTATIVE GENUINE GENETIC VARIANT
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	135035	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS
TRANSLATIONAL GENOMICS RES INSTITUTE
445 N 5TH ST SUITE 600	PHOENIX	AZ	85004	753065445	501(C)(3)	225000	INFLAMMATION AND THROMBOSIS GENE PATHWAYS AND CARDIOVASC
TRUSTEES OF COLUMBIA UNIVERSITY IN NY
P O BOX 29789	NEW YORK	NY	100879789	135598093	501(C)(3)	1436339	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
TRUSTEES OF THE UNIV OF PENNSYLVANIA
3451 WALNUT ST	PHILADELPHIA	PA	191046205	231352685	501(C)(3)	2770	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
TRUSTEES OF THE UNIV OF PENNSYLVANIA
3451 WALNUT ST	PHILADELPHIA	PA	191785541	231352685	501(C)(3)	6182	GENOME-WIDE ASSOCIATION STUDY OF ENDOMETRIAL CANCER
TRUSTEES OF THE UNIV OF PENNSYLVANIA
3451 WALNUT ST	PHILADELPHIA	PA	191785541	231352685	501(C)(3)	1204938	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
TRUSTEES OF THE UNIV OF PENNSYLVANIA
3451 WALNUT ST	PHILADELPHIA	PA	191046205	231352685	501(C)(3)	169780	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS
UNIVERSITY OF ALABAMA BIRMINGHAM
1530 THIRD AVENUE SOUTH	BIRMINGHAM	AL	352940109	636005396	UNIVERSITY	932250	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
UNIVERSITY OF FLORIDA
P O BOX 113001	GAINESVILLE	FL	326113001	596002052	UNIVERSITY	90229	METHODS FOR EVALUATING VACCINE EFFICACY
UNIVERSITY OF GEORGIA RESEARCH
475 N LUMPKIN ST	ATHENS	GA	30602	581353149	501(C)(3)	182315	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME
UNIVERSITY OF GEORGIA RESEARCH
475 N LUMPKIN ST	ATHENS	GA	30602	581353149	501(C)(3)	26819	FUNCTIONAL METHODS FOR RADIATION EXPOSURE AND BIOMARKER
UNIVERSITY OF HAWAII
2530 DOLE ST	HONOLULU	HI	96822	996000354	UNIVERSITY	100354	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
UNIVERSITY OF IDAHO
P O BOX 443020	MOSCOW	ID	838443020	826000945	UNIVERSITY	70933	WASHINGTON VACCINE ALLIANCE
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	871310001	856000642	UNIVERSITY	4849	REDUCING OBESITY AT THE WORKPLACE: A RANDOMIZED TRIAL
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	871310001	856000642	UNIVERSITY	26686	TREC COORDINATION CENTER
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	871310001	856000642	UNIVERSITY	295	TREC: MECHANISMS OF ENERGY BALANCE AND CANCER PREVENTION
UNIVERSITY OF NEW MEXICO
1 UNIVERSITY OF NEW MEXICO	ALBUQUERQUE	NM	871310001	856000642	UNIVERSITY	298854	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES
UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE
9201 UNIVERSITY CITY BOULEVARD	CHARLOTTE	NC	282230001	560791228	UNIVERSITY	80319	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	165208	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	248140	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	7058	MEASUREMENT OF CANCER-ASSOCIATED BIOMARKER PROTEINS IN C
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	84666	MECHANISM-BASED CLASSIFICATION AND TARGETING OF CASTRATI
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	45014	OBJECTIVE PHYSICAL ACTIVITY AND CARDIOVASCULAR HEALTH IN
UNIVERSITY OF NORTH CAROLINA
P O BOX 402420	ATLANTA	GA	303842420	566001393	UNIVERSITY	37249	STATISTICAL METHODS IN HIV VACCINE EFFICACY TRIALS
UNIVERSITY OF PITTSBURGH
P O BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	5495	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF PITTSBURGH
P O BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	20373	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
UNIVERSITY OF PITTSBURGH
P O BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	11967	EPIDEMIOLOGY OF PUTATIVE GENETIC GENETIC VARIANTS IN THE
UNIVERSITY OF PITTSBURGH
P O BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	21893	GWAS OF HORMONE TREATMENT AND CVD AND METABOLIC OUTCOMES
UNIVERSITY OF PITTSBURGH
P O BOX 371220	PITTSBURGH	PA	152517220	250965591	501(C)(3)	27297	HVTN LABORATORY PROGRAM
UNIVERSITY OF ROCHESTER
910 GENESEE ST SUITE 200	ROCHESTER	NY	146113847	160743209	501(C)(3)	1326849	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
UNIVERSITY OF ROCHESTER
910 GENESEE ST SUITE 200	ROCHESTER	NY	146113847	160743209	501(C)(3)	141355	THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900742095	951642394	501(C)(3)	101314	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900898001	951642394	501(C)(3)	8426	BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM - SUPPLEMEN
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900742095	951642394	501(C)(3)	83916	COG CHAIR'S GRANT - PROJECT TARGET IDENTIFICATION FOR HI
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900742095	951642394	501(C)(3)	120605	IMPROVING EARLY DETECTION OF BREAST CANCER
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900742095	951642394	501(C)(3)	6287	IRF8 AS A BIOMARKER OF AGING, MALIGNANT TRANSFORMATION,
UNIVERSITY OF SOUTHERN CALIFORNIA
3500S FIGUEROA ST SUITE 102	LOS ANGELES	CA	900898015	951642394	501(C)(3)	24648	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM: PHASE
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL
P O BOX 841765	DALLAS	TX	752841765	756002868	UNIVERSITY	807800	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
UNIVERSITY OF TEXAS MD ANDERSON
P O BOX 4390	HOUSTON	TX	772104390	746001118		36960	IMPROVING EARLY DETECTION OF BREAST CANCER WITH A BLOOD
UNIVERSITY OF TEXAS MD ANDERSON
P O BOX 4390	HOUSTON	TX	772104390	746001118		19483	THE BREAST CANCER BIOMARKER DISCOVERY CONSORTIUM: PHASE
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 406	SALT LAKE CITY	UT	841129020	876000525	UNIVERSITY	85837	GENOME-WIDE ASSOCIATION STUDY OF NONSYNONYMOUS SNPS IN C
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 406	SALT LAKE CITY	UT	841129020	876000525	UNIVERSITY	28420	PROSTAGLANDIN SYNTHESIS, GENETICS AND COLORECTAL CANCER
UNIVERSITY OF UTAH
201 S PRESIDENTS CIRCLE RM 406	SALT LAKE CITY	UT	841129020	876000525	UNIVERSITY	32483	THE TIME DISTRIBUTION METHOD FOR MEASURING CLINICALLY VA
UNIVERSITY OF VERMONT AND
85 SOUTH PROSPECT ST	BURLINGTON	VT	054050160	030179440	UNIVERSITY	12003	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	14577	A MULTI-STATE STUDY OF CANCER TREATMENT AND OUTCOME AMON
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	27655	A PROSPECTIVE STUDY OF COLORECTAL CANCER: ONE-CARBON ME
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	57410	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	13173	ADIPOSE TISSUE INFLAMMATION AND ESTROGEN SYNTHESIS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	12862	AFFINITY BASED STRATEGIES TO FAST TRACK DEVELOPMENT OF C
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	12989	AIDS MALIGNANCY CLINICAL TRIALS (AMC)
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	27112	AIDS MALIGNANCY CLINICAL TRIALS CONSORTIUM (AMC)
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1059	AN ALGORITHM FOR CONTROL OF BIOLOGICAL TIME
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	5582	ANALYSIS OF A NOVEL SUBSET OF HUMAN CD8+ MEMORY CELLS WI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	54703	ANALYZING HETEROGENEITY OF ONCOGENIC PATHWAY ACTIVATION
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	23037	ASTATINE-211 CONDITIONING FOR NONMYELOABLATIVE HEMOPOIET
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	43361	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1924553	CANCER CENTER SUPPORT GRANT (COMPREHENSIVE)
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	457568	CANCER IMMUNOTHERAPY TRIALS NETWORK CENTRAL OPERATIONS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	39342	CD38 PRETARGETED RADIOIMMUNOTHERAPY FOR MYELOMA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	68367	CD45 PRETARGETED RADIOIMMUNOTHERAPY FOR AML
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	133111	CD8+ CELL IMMUNITY TO CYTOMEGALOVIRUS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	313388	CENTER FOR BIOLOGICAL FUTURES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	137821	CENTER FOR COMPARATIVE EFFECTIVENESS RESEARCH IN CANCER
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	172248	CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	95818	CHEMOPROTECTION AGAINST AMINOGLYCOSIDE-INDUCED OTOTOXICI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	3615	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1623449	CLINICAL EPIDEMIOLOGY AND PATHOGENESIS OF ASYMPTOMATIC H
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	92600	COLORECTAL CANCER GENOME-WIDE ASSOCIATION STUDIES CONSOR
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	748752	CONSORTIUM BIOSPECIMEN PROGRAM
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	132966	CONTROLLING HEMATOPOIETIC LINEAGE COMMITMENT FROM ESC TO
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	89571	CORD BLOOD EXPANSION AND TRANSPLANTATION IN A NON-HUMAN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	3119	CORE ASSAYS MRLI - W1, W3
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	6345	CORE CENTER OF EXCELLENCE IN HEMATOLOGY
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	137620	CYTOTOXIC T CELL RESPONSE TO HSV IN HIV INFECTED PEOPLE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	27998	CYTOTOXIC T-CELL REPONSES TO HSV IN HIV-INFECTED PERSONS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	175698	DEVELOPMENT OF NOVEL AIDS GENE THERAPY STRATEGIES IN THE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	275024	DEVELOPMENT OF SAFE AND EFFICIENT GENE THERAPY STRATEGIE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	3452	DIETARY FRUCTOSE AND LOW-GRADE INFLAMMATION
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	290524	EARLY AND REINFECTION IN HIGH RISK WOMEN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	28438	ENHANCING LONG-TERM 5-A-DAY BEHAVIOR CHANGE IN WORKSITES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	32990	EVALUATION OF A HEPATITIS B OUTREACH INTERVENTION FOR CA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	8250	EXOSOMAL RNAS SERUM PROSTATE CANCER BIOMARKERS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	216744	EXPANSION OF CARDIAC AND HEMATOPOIETIC PREGENITORS BY WN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	73813	FHCRC/UW CANCER CONSORTIUM PHASE I CLINICAL TRIALS PROGR
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	4165	FOAMY VIRUS ZOONOTIC TRANSMISSION FROM NEW WORLD MONKEYS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	111497	FRED HUTCHINSON/UNIVERSITY OF WASHINGTON CANCER CONSORTI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	5722	GENE THERAPY FOR FANCONI ANEMIA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	4825	HEMATOPOIETIC CHEMOPROTECTION IN GLIOBLASTOMA PATIENTS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	220067	HPTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWO
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	25733	HPV CAPSID ANTIBODIES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	8864	HPV: BIOLOGY, CLINICAL SIGNIFICANCE AND EPIDEMIOLOGY
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	2952256	HVTN LABORATORY PROGRAM
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	66520	HVTN SDMC: LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWO
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	3809825	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	6631	IDENTIFY AND VALIDATE NOVEL EPIGENETIC MOLECULAR MARKERS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	266	IMMUNE CORRELATES OF PROTECTION AGAINST HIV AND SIV INFE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	82734	IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	53177	IN UTERO TRANSPLANTATION IN PRIMATES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	34320	IN VIVO EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON NORMA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	25033	INFLAMMATORY DENDRITIC CELLS IN ADIPOSE TISSUE INFLAMMAT
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	751	INNATE RESISTANCE TO MUCOSAL HSV INFECTION IN HUMANS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	321559	INTERGRATED SENSOR TECHNOLOGY FOR REAL-TIME RECORDING OF
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	31971	LAGLIDADG DELIVERY AND GENE REPAIR IN CANINE HEMATOPOIET
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	7024	LATE EFFECTS OF TREATMENT IN WILMS TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	80151	LATE EFFECTS OF TREATMENT IN WILMS-TUMOR SURVIVORS AND O
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	75479	LEADERSHIP FOR HIV/AIDS CLINICAL TRIALS NETWORKS: MICRO
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	16460	LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL TRIAL
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	22287	LIVESTRONG SURVIVORSHIP CENTER OF EXCELLENCE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	816	LYMPH NODE ALTERATIONS IN CANCER
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1340772	MECHANISMS AND COFACTORS OF HIV TRANSMISSION TO WOMEN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	53100	MENOPAUSAL SYMPTOMS INITIATIVE-FINDING LASTING ANSWERS F
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	99325	MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	55971	MODELING PROSTATE CANCER CONTROL: PREVENTION, SCREENING,
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	10352	NIGHT SHIFT WORK AND HORMONE LEVELS IN MEN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	17774	NORTH AMERICAN SHWACHMAN-DIAMOND SYNDROME REGISTRY
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	77876	NOVEL COMPUTATIONAL TOOLS FOR STUDYING THE HUMAN MICROBI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	205953	NOVEL CULTIVATION METHODS FOR THE DOMESTICATION OF VAGIN
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	15906	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	10940	ORAL CANCER: MOLECULAR PROFILES & CLINICAL OUTCOMES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	20088	OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	440932	PACIFIC OVARIAN CANCER RESEARCH CONSORTIUM
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	49710	PRECLINICAL GENE THERAPY STUDIES IN CANINE MUSCULAR DYST
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	4312	PRE-DOCTORAL FELLOW - KELLIE VIGNA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	73202	PRETARGETED RADIOIMMUNOTHERAPY OF CD20+ LYMPHOMAS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	13689	PROSPR: STATISTICAL COORDINATING CENTER (PSCC)
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1228	PROTEIN BIOMARKERS IN CHILDHOOD ACUTE MYELOID LEUKEMIA
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	12143	RADIATION DOSE-DEPENDENT INTERVENTIONS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	16667	REDUCING OBESITY AT THE WORKPLACE: A RANDOMIZED TRIAL
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	337532	SEATTLE CANCER CONSORTIUM BREAST SPORE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	302981	SEATTLE VACCINE TRIALS UNIT
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	32242	STATISTICAL METHODS FOR MEDICAL STUDIES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	89248	STATISTICAL METHODS IN HIV/AIDS RESEARCH
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	143667	STRATEGIES TO IMPROVE THE ADOPTIVE TRANSFER OF T CELLS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	233183	T CELL IMMUNITY TO HSV-2 IN IMMUNE SERONEGATIVE SUBJECTS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	237900	TARGETED MODIFICATION OF HOST AND PROVIRAL DNA TO TREAT
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	14750	TARGETED RADIOTHERAPY WITH 90Y-BC8 MONOCLONAL ANTIBODY,
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	1955	TGF-BETA SIGNALING AND COLON CANCER
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	20504	THE FANCONI ANEMIA-BRCA PATHWAY AND CHEMOSENSITIVITY OF
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	555069	THE PACIFIC NORTHWEST PROSTATE CANCER SPORE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	263959	THE PATHOGENESIS OF FMD: FACIOSCAPULOHUMERAL MUSCULAR
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	77508	THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSI
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	13615	THE ROLE OF UNCULTIVATED BACTERIA IN BACTERIAL VAGINOSIS
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	233286	THERAPY OF LYMPHOMA/LEUKEMIA WITH MONOCLONAL ANTIBODIES
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	170107	UNDERSTANDING AND PREVENTING BREAST CANCER DISPARITIES I
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	181866	WASHINGTON VACCINE ALLIANCE
UNIVERSITY OF WASHINGTON
NE COLUMBIA RD	SEATTLE	WA	98105	916001537	UNIVERSITY	63443	WEIGHT LOSS AND EXERCISE EFFECTS ON TELOMERE LENGTH IN P
UNIVERSITY OF WISCONSIN
DRAWER 538	MILWAUKEE	WI	532780538	396006492	UNIVERSITY	2638	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
UNIVERSITY OF WISCONSIN
DRAWER 538	MILWAUKEE	WI	532780538	396006492	UNIVERSITY	15669	NUTRITION AND PHYSICAL ACTIVITY ASSESSMENT STUDY (NPAAS)
VACCINE & GENE THERAPY INSTITUTE FLORIDA
9801 SW DISCOVERY WAY PORT ST	LUCIE	FL	34987	364631835	501(C)(3)	297409	HVTN LABORATORY PROGRAM
VANDERBILT UNIVERSITY
DEPT OF FINANCE DEPT AT 40303	ATLANTA	GA	311920303	620476822	501(C)(3)	1326637	HVTN: LEADERSHIP GROUP FOR A GLOBAL HIV VACCINE CLINICAL
VANDERBILT UNIVERSITY
DEPT OF FINANCE DEPT AT 40303	ATLANTA	GA	311920303	620476822	501(C)(3)	17872	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
VANDERBILT UNIVERSITY
DEPT OF FINANCE DEPT AT 40303	ATLANTA	GA	311920303	620476822	501(C)(3)	13815	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
VANDERBILT UNIVERSITY
DEPT OF FINANCE DEPT AT 40303	ATLANTA	GA	311920303	620476822	501(C)(3)	25180	OUTCOMES BASED GUIDELINE DEVELOPMENT FOR PROSTATE CANCER
VANDERBILT UNIVERSITY
2301 VANDERBILT PLACE PMB 401591	NASHVILLE	TN	372401591	620476822	501(C)(3)	64074	TILLING THE ZEBRAFISH GENOME: A REVERSE GENETICS APPROAC
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BOULEVARD	WINSTONSALEM	NC	27157	223849199	501(C)(3)	26851	A RANDOMIZED PHASE II TRIAL OF CMV PREVENTION IN ACUTE L
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BOULEVARD	WINSTONSALEM	NC	27157	223849199	501(C)(3)	21389	CLINICAL COORDINATING CENTER FOR THE WOMEN'S HEALTH INIT
WASHINGTON STATE UNIVERSITY
P O BOX 641039	PULLMAN	WA	991641039	916001108	UNIVERSITY	21434	ENGINEERING ENZYMES FOR ANTI-TUMOR SUICIDE GENE THERAPY
WASHINGTON STATE UNIVERSITY
P O BOX 641039	PULLMAN	WA	991641039	916001108	UNIVERSITY	69119	WASHINGTON VACCINE ALLIANCE
WASHINGTON UNIVERSITY
700 ROSEDALE AVE CAMPUS BOX 1034	ST LOUIS	MO	631121408	430653611	501(C)(3)	2186	IMMUNE MEDIATED DISORDERS AFTER ALLOGENEIC HEMATOPOIETIC
WASHINGTON UNIVERSITY
700 ROSEDALE AVE CAMPUS BOX 1034	ST LOUIS	MO	631121408	430653611	501(C)(3)	6632	IMPROVING OUTCOMES ASSESSMENT IN CHRONIC GVHD
WASHINGTON UNIVERSITY
700 ROSEDALE AVE CAMPUS BOX 1034	ST LOUIS	MO	631121408	430653611	501(C)(3)	4436	RADIATION DOSE-DEPENDENT INTERVENTIONS
YAKIMA VALLEY FARM WORKERS CLINIC
518 W FIRST AVENUE	TOPPENISH	WA	98948	911019392	501(C)(3)	37270	CENTER FOR HISPANIC HEALTH PROMOTION: REDUCING CANCER DI
YALE UNIVERSITY
P O BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	104460	ADULT LEUKEMIA RESEARCH CENTER
YALE UNIVERSITY
P O BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	22357	BARRETT'S AND ESOPHAGEAL ADENOCARCINOMA GENETIC SUSCEPTI
YALE UNIVERSITY
P O BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	42591	HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMIS
YALE UNIVERSITY
P O BOX 1873	NEW HAVEN	CT	065081873	060646973	501(C)(3)	20664	TREC COORDINATION CENTER

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	344	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	13	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	PROCEDURE FOR MONITORING GRANTS IN THE U.S.:	Identifier
Return Reference	PART I, LINE 2:	ReturnReference
Explanation	SCHEDULE I, PART I, LINE 2: ONCE THE NOTICE OF AWARD HAS BEEN RECEIVED AND THE CENTER PROJECT IDENTIFICATION ACTIVATED, THE SUBAWARD CAN BE SET UP. THE STRUCTURE OF THE SUBAWARD WILL DEPEND ON HOW THE PRIME IS SET UP. GENERALLY, AT THE CENTER, A NEW PURCHASE ORDER (PO) IS REQUISITIONED FOR EACH SUBAWARD FOR EACH YEAR OF A PROJECT. THIS ALLOWS THE RESEARCH COORDINATOR (RC) TO CLOSELY MONITOR SUBAWARD INVOICES AND ENCUMBRANCES. FOR OUR SUBRECIPIENTS, IT MEANS A SEPARATE BUDGET IDENTIFICATION AND FINAL INVOICE EACH YEAR. CARRYOVER BETWEEN YEARS IS NOT AUTOMATIC. THERE ARE 5 PRIMARY STEPS IN THIS PROCESS: 1) STEP ONE IS WITHIN THE OFFICE OF SPONSORED RESEARCH (OSR). THE GRANT SPECIALIST NOTIFIES THE CONTRACT SPECIALIST THAT A GRANT WHICH INCLUDES A SUBAWARD HAS BEEN FUNDED, AND PROVIDES TO THE CONTRACT SPECIALIST A COPY OF THE AWARD, THE SIGNED SUBAWARD APPLICATION (IF AVAILABLE) AND ANY SPECIAL INSTRUCTIONS. A SIGNED SUBAWARD APPLICATION IS IMPORTANT BECAUSE IT SHOWS THAT THE SUBRECIPIENT ORGANIZATION HAS REVIEWED AND APPROVED THE BUDGET AND SCOPE OF WORK, 2) THE RC SENDS THE CONTRACT SPECIALIST A SUBCONTRACT ACQUISITION FORM (SAF). THIS FORM PROVIDES AUTHORIZATION FOR THE CONTRACT SPECIALIST TO ISSUE THE SUBAWARD, AND INCLUDES A SCOPE OF WORK, BUDGET, AND PERTINENT SUBRECIPIENT INFORMATION. IT IS NECESSARY TO PROVIDE THE SCOPE OF WORK AND BUDGET ON THE SAF AS THESE ITEMS MAY HAVE CHANGED FROM WHAT WAS ORIGINALLY SUBMITTED IN THE SUBAWARD APPLICATION, 3) THE CONTRACT SPECIALIST REQUISITIONS THE SUBAWARD PO, WHICH THE RC MUST APPROVE. AN E-MAIL IS SENT TO THE RC NOTIFYING THEM THAT THE REQUISITION IS PENDING AND REQUIRES APPROVAL. BECAUSE OSR DOES NOT HAVE FUNDS COMMITMENT AUTHORITY, THE RC IS REQUIRED TO APPROVE ALL REQUISITIONS, 4) OSR COLLECTS INFORMATION REQUIRED TO CORRECTLY SET UP THE SUBAWARD. THESE ITEMS INCLUDE INSTITUTIONAL REVIEW OFFICE (IRO) AND INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) APPROVAL DATES, CONFIRMATION OF SUBAWARD FACILITIES AND ADMINISTRATIVE (F&A) RATES AND A-133 AUDIT REPORTS, REVIEW OF PRIME SPECIAL TERMS AND CONDITIONS TO DETERMINE FLOW-DOWN, CONFIRMATION THAT THE SUBRECIPIENT IS NOT DEBARRED, AND OTHER SIMILAR REGULATORY AND ADMINISTRATIVE REQUIREMENTS. WHILE MUCH OF THE INFORMATION IS COLLECTED BY OSR, THE RC MAY, IN ADDITION TO COMPLETING THE SAF, BE ASKED TO ASSIST IN THE COLLECTION OF SOME OF THE DOCUMENTATION AND FINALLY, 5) OSR WRITES THE SUBAWARD AGREEMENT, AND MAILS IT TO THE SUBRECIPIENT FOR SIGNATURE. SOME AGREEMENTS CAN BE SIGNED BY OSR BEFORE MAILING, WHILE OTHERS WILL BE SENT UNSIGNED. THIS IS DETERMINED BY THE CONTRACT SPECIALIST BASED ON THE TERM OF AWARD AND STATUS OF ADMINISTRATIVE AND REGULATORY REQUIREMENTS. A COPY OF THE INITIAL SUBAWARD IS SENT TO THE RC ONCE THE SUBAWARD HAS BEEN FULLY SIGNED. NO INVOICES SHOULD BE APPROVED BY THE RC UNTIL THEY HAVE RECEIVED A FULLY EXECUTED AGREEMENT.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	X	FirstClassOrCharterTravel
Travel For Companions	X	TravelForCompanions
Club Dues Or Fees	X	ClubDuesOrFees
Written Policy Re T And E Expenses	1	WrittenPolicyReTAndEExpenses
Substantiation Required	1	SubstantiationRequired
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	0	SeverancePayment
Supplemental Nonqual Retire Plan	0	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	0	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	0	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	0	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	0	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	0	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	1	AnyNonFixedPayments
Initial Contract Exception	0	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (23 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
LAWRENCE COREY MD
606356	0	156250	0	16500	0	0	0	45396	0	824502	0	0	0
FREDERICK R APPELBAUM MD
523908	0	113871	0	0	0	0	0	44646	0	682425	0	0	0
JANELL E BALDWIN
203707	0	20000	0	0	0	0	0	36040	0	259747	0	0	0
ANTHONY J BOZZUTI
233912	0	30000	0	16500	0	0	0	48361	0	328773	0	0	0
JONATHAN A COOPER PHD
282131	0	0	0	0	0	0	0	42684	0	324815	0	0	0
SUSAN C DOLBERT PHD
133580	0	50000	0	0	0	0	0	3060	0	186640	0	0	0
LINDA L GAINER
223902	0	25000	0	0	0	0	0	39739	0	288641	0	0	0
DENISE GALLOWAY PHD
280411	0	0	0	0	0	0	0	43604	0	324015	0	0	0
MARK T GROUDINE MD PHD
412578	0	125000	0	0	0	0	0	45318	0	582896	0	0	0
RANDALL C MAIN
339545	0	50000	0	0	0	0	0	45222	0	434767	0	0	0
MARGARET JULIANA MCELRATH MD PHD
298002	0	0	0	14400	0	0	0	43008	0	355410	0	0	0
ULRICH W MUELLER PHD
234166	0	30000	0	0	0	0	0	48244	0	312410	0	0	0
HOWARD ALBERT NACHTRIEB
218893	0	30000	0	0	0	0	0	48138	0	297031	0	0	0
ROSS L PRENTICE PHD
414412	0	0	0	0	0	0	0	45279	0	459691	0	0	0
SCOTT N RUSCH
186791	0	20000	0	0	0	0	0	39762	0	246553	0	0	0
DOUGLAS J SHAEFFER
305080	0	30000	0	0	0	0	0	45507	0	380587	0	0	0
MYRA H TANITA
408704	0	75000	0	6000	0	0	0	40138	0	529842	0	0	0
STEVEN G SELF PHD
274341	0	0	0	16500	0	0	0	44420	0	335261	0	0	0
SAMIR M HANASH MD
337366	0	0	0	0	0	0	0	43774	0	381140	0	0	0
MARTIN A CHEEVER MD
270695	0	0	0	16500	0	0	0	41796	0	328991	0	0	0
IRWIN D BERNSTEIN MD
291183	0	0	0	16500	0	0	0	42614	0	350297	0	0	0
JANET LEE STANFORD MD
250446	0	0	0	16500	0	0	0	48447	0	315393	0	0	0
BRIAN J REID MD
265064	0	0	0	0	0	0	0	44947	0	310011	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)

Return ReferenceReturnReference

ExplanationExplanation

PART I, LINE 1A

FIRST CLASS AIR TRAVEL IS ALLOWED CONSISTENT WITH FEDERAL REIMBURSEMENT REGULATIONS AND GENERALLY ONLY WHEN COACH FARE IS NOT AVAILABLE. AIRFARE AND NORMAL TRAVEL EXPENSES ARE PAID FOR THE PRESIDENT AND DIRECTOR'S SPOUSE FOR TRIPS INVOLVING FUNDRAISING FOR THE CENTER. SOCIAL CLUB DUES ARE PAID FOR THE CENTER'S PRESIDENT & DIRECTOR AND VICE PRESIDENT OF DEVELOPMENT. NONE OF THESE ITEMS ARE CONSIDERED TAXABLE COMPENSATION TO THESE INDIVIDUALS.

PART I, LINE 7

THE BONUS ARRANGEMENT FOR ALL OFFICERS, KEY EMPLOYEES AND HIGHLY COMPENSATED EMPLOYEES IS DISCRETIONARY AND ENTIRELY PERFORMANCE BASED.

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing	CUSIP NumberCUSIPNumber
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	2007-11-15	5200000	REIMBURSE THE CENTER FOR COSTS OF ACQUIRING REAL PROPERTY & IMPROVEMENTS	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	2009-11-24	15381009	REFUND BONDS ISSUED 11/1/2002	0	0	0	93978E6G2
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	2009-11-24	8842608	REFUND BONDS ISSUED 11/1/2002	0	0	0	93978E6G2
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	2009-11-24	32093411	REFUND BONDS ISSUED 11/1/2002	0	0	0	93978E6G2

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Capital ExpendituresCapitalExpenditures	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind	Amount In Reserve FundAmountInReserveFund	Other Spent ProceedsOtherSpentProceeds
557339	5200000	35948	32182	5131870	2007	0	1	1
837034	15381009	169304	69174		2009	1	1	1	1466385	13676147
481214	8842608	97333	39769		2009	1	1	1	843031	7862475
1746522	32093411	353262	144336		2009	1	1	1	3059701	28536111

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0
0	0	0	0	0	0

Field	Value	IRS element (for citing)
Fed Tax Requirements Compliance	X	FedTaxRequirementsCompliance

Form990 Schedule K Part VI Form990ScheduleKPartVI (2 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
SCHEDULE K, PART I, BOND N	DESCRIPTION OF PURPOSE	TO REPAY A TAXABLE BRIDGE LOAN INCURRED BY THE CENTER TO ACQUIRE LAND AND THE 1100 EASTLAKE BUILDING IN SEATTLE, WASHINGTON. TO CONSTRUCT, REMODEL, RENOVATE AND EQUIP HEALTH CARE FACILITIES LOCATED AT THE 1100 EASTLAKE BUILDING AND AT THE CENTER'S EXISTING SOUTH LAKE UNION CAMPUS IN SEATTLE. TO CONSTRUCT A CONNECTION BETWEEN THE 1100 EASTLAKE BUILDING AND THE SOUTH LAKE UNION CAMPUS.
SCHEDULE K, PART I		THE BOND ISSUES LISTED IN PART I WITH CUSIP NUMBERS 93978E6G2 (ALL ROWS), 93978HCL7 (ALL ROWS), 93978HBT1 (ALL ROWS) AND 93978HBV6 (ROW A ONLY) ARE POST-DECEMBER 31, 2002 REFUNDING ISSUES WHICH REFUND PRE-JANUARY 1, 2003 BOND ISSUES AND ARE THEREFORE NOT INCLUDED IN PART III, PRIVATE BUSINESS USE.

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978E6G2	2009-11-24	18735275	REFUND BONDS ISSUED 11/1/2002	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978E6G2	2009-11-24	39972686	REFUND BONDS ISSUED 11/15/2001	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929		2010-11-04	30000000	ACQUISITION OF A SIX-STORY OFFICE BUILDING	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HCL7	2011-06-30	49522564	REFUND BONDS ISSUED 11/15/2001	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Amount In Reserve FundAmountInReserveFund	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Other Spent ProceedsOtherSpentProceeds	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind	Capital ExpendituresCapitalExpenditures
1019571	18735275	1786172	206225	84260	16658619	2009	1	1	1
1120659	39972686	3829025	627017		35516644	2009	1	1	1
840000	30000000		367238	416292		2010	1	1	1	29216470
298325	49522564		646773	29219	48846572	2011	0	1	1

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs	Engage Bond Counsel ContractsEngageBondCounselContracts
0	0.00000	0.00000	1
0	0.00000	0.00000	1
1	0.00500	0.00500	1	1
0	0.00000	0.00000	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
0	0	0	0	0	0
0	0	0	0	0	0
0	1	0	0	0	0
0	0	0	0	0	0

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (4 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HCL7	2011-06-30	33478278	REFUND BONDS ISSUED 11/24/2009	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HBT1	2011-06-30	34532776	REFUND BONDS ISSUED 11/15/2001	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HBT1	2011-06-30	17411441	REFUND BONDS ISSUED 11/24/2009	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HBT1	2011-06-30	5580783	REFUND BONDS ISSUED 11/24/2009	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (4 entries)

Amount RetiredAmountRetired	Total ProceedsTotalProceeds	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Working Capital ExpendituresWorkingCapitalExpenditures	Other Spent ProceedsOtherSpentProceeds	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind	Credit EnhancementCreditEnhancement	Amount UnspentAmountUnspent
201675	33478278	437232	19752	33021294	2011	1	1	1
	34532776	285850		33968689	2011	1	1	1	267781	10455
	17411441	144126		17127028	2011	1	1	1	135016	5271
	5580783	46196		5489622	2011	1	1	1	43276	1690

Form990 Schedule K Part III Form990ScheduleKPartIII (4 entries)

Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (4 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate	Term Of HedgeTermOfHedge	Superintegrated HedgeSuperintegratedHedge	Hedge TerminatedHedgeTerminated
(no name)
0	0	0	0	0	0
BARCLAYS BANK PLC
0	1	1	0	0	0	16.500000000000	0	0
BARCLAYS BANK PLC
0	1	1	0	0	0	16.500000000000	0	0
BARCLAYS BANK PLC
0	1	1	0	0	0	16.500000000000	0	0

Schedule K IRS990ScheduleK

Form990 Schedule K Part I Form990ScheduleKPartI (2 entries)

Issuer EINIssuerEIN	CUSIP NumberCUSIPNumber	Date IssuedDateIssued	Issue PriceIssuePrice	Description Of PurposeDescriptionOfPurpose	DefeasedDefeased	On Behalf Of IssuerOnBehalfOfIssuer	Pool FinancingPoolFinancing
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HBV6	2011-06-30	352651	REFUND BONDS ISSUED 11/24/2009	0	0	0
WASHINGTON HEALTH CARE FACILITIES AUTHORITY
911108929	93978HBV6	2011-06-30	84147349	SEE PART VI	0	0	0

Form990 Schedule K Part II Form990ScheduleKPartII (2 entries)

Total ProceedsTotalProceeds	Issuance Costs From ProceedsIssuanceCostsFromProceeds	Credit EnhancementCreditEnhancement	Other Spent ProceedsOtherSpentProceeds	Amount UnspentAmountUnspent	Year Of Subst CompletionYearOfSubstCompletion	Current RefundingCurrentRefunding	Advance RefundingAdvanceRefunding	Final Allocation MadeFinalAllocationMade	Adequate Books And Recds MaintaindAdequateBooksAndRecdsMaintaind	Capitalized InterestCapitalizedInterest	Capital ExpendituresCapitalExpenditures
352651	1779	3653	346887	332	2011	1	0	1	1
84147349	424356	871651		18605334	2012	0	0	0	0	3488245	60757763

Form990 Schedule K Part III Form990ScheduleKPartIII (2 entries)

Owning Bond Financed PropertyOwningBondFinancedProperty	Any Lease ArrangementsAnyLeaseArrangements	Mngment Cntrct Bond Financd PrprtyMngmentCntrctBondFinancdPrprty	Any Research AgreementsAnyResearchAgreements	Prcntge Prvt Business Use By OthersPrcntgePrvtBusinessUseByOthers	Percentage Of Prvt Business Re UBIPercentageOfPrvtBusinessReUBI	Total Private Business UseTotalPrivateBusinessUse	Post Issuance Compliance ProcdrsPostIssuanceComplianceProcdrs
0	0	0	0	0.00000	0.00000	0.00000	1
0	0	0	0	0.00000	0.00000	0.00000	1

Form990 Schedule K Part IV Form990ScheduleKPartIV (2 entries)

Form8038 T FiledForm8038TFiled	Variable Rate IssueVariableRateIssue	Hedge Identified In Books And RecdsHedgeIdentifiedInBooksAndRecds	Term Of HedgeTermOfHedge	Superintegrated HedgeSuperintegratedHedge	Hedge TerminatedHedgeTerminated	Gross Proceeds Invested In GICGrossProceedsInvestedInGIC	Gross Proceeds InvestedGrossProceedsInvested	Exception To RebateExceptionToRebate
BARCLAYS BANK PLC
0	1	1	19.500000000000	0	0	0	0	0
BARCLAYS BANK PLC
0	1	1	19.500000000000	0	0	0	0	0

Schedule L IRS990ScheduleL

Form990 Schedule L Part IV Form990ScheduleLPartIV

Name Of Interested Person NameOfInterestedPerson

Name Business NameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	IKARIA INC	BusinessNameLine1

Field	Value	IRS element (for citing)
Relationship	ROBERT NELSEN ORGANIZATION TRUSTEE IS A DIRECTOR OF IKARIA	Relationship
Amount Of Transaction	666296	AmountOfTransaction
Description Of Transaction	DIVIDEND INCOME RECEIVED FROM INTERESTED PERSON	DescriptionOfTransaction
Sharing Of Revenues	0	SharingOfRevenues

Schedule M IRS990ScheduleM

Works Of Art WorksOfArt

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	1	NumberOfContributions
Noncash Contribs Rptd F990	22000	NoncashContribsRptdF990
Method Of Determining Revenues	APPRAISAL	MethodOfDeterminingRevenues

Securities Publicly Traded SecuritiesPubliclyTraded

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	31	NumberOfContributions
Noncash Contribs Rptd F990	4661305	NoncashContribsRptdF990
Method Of Determining Revenues	MARKET VALUE	MethodOfDeterminingRevenues

Other Non Cash Contributions Table OtherNonCashContributionsTable (3 entries)

Non Cash CheckboxNonCashCheckbox	DescriptionDescription	Number Of ContributionsNumberOfContributions	Noncash Contribs Rptd F990NoncashContribsRptdF990	Method Of Determining RevenuesMethodOfDeterminingRevenues
X	EQUIPMENT	3	1132526	MARKET VALUE
X	PILLOWS	1	4900	MARKET VALUE
X	AUCTION ITEMS	308	440458	MARKET VALUE

Field	Value	IRS element (for citing)
Number Of8283 Received	1	NumberOf8283Received
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts	1	ReviewProcessUnusualNCGifts
Third Parties Used	0	ThirdPartiesUsed

Form990 Schedule M Part II Form990ScheduleMPartII

Field	Value	IRS element (for citing)
Identifier	METHOD FOR DETERMINING NUMBER OF CONTRIBUTORS:	Identifier
Return Reference	PART I, COLUMN (B):	ReturnReference
Explanation	THE NUMBER IN PART I, COLUMN (B) REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED.	Explanation

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (5 entries)

Return ReferenceReturnReference	ExplanationExplanation	IdentifierIdentifier
FORM 990, PART VI, SECTION B, LINE 11	UNDER THE CENTER'S BYLAWS, THE FINANCE COMMITTEE IS RESPONSIBLE FOR REVIEWING AND INVESTIGATING FINANCIAL TRANSACTIONS OF FHCRC INCLUDING RESPONSIBILITY OF INTERNAL AND EXTERNAL AUDITING AND FOR MAKING RECOMMENDATIONS TO THE BOARD CONCERNING THESE MATTERS. FHCRC'S VICE PRESIDENT OF FINANCE & CHIEF FINANCIAL OFFICER AND HIS STAFF WORK CLOSELY WITH THE OUTSIDE ACCOUNTING FIRM FHCRC ENGAGES TO PREPARE THE FORM 990. THE DRAFT FORM 990 IS ALSO REVIEWED BY THE CORPORATE TREASURER, THE EXECUTIVE VICE PRESIDENT & CHIEF OPERATING OFFICER AND THE VICE PRESIDENT & GENERAL COUNSEL PRIOR TO PROVIDING IT TO THE FINANCE COMMITTEE. THE FINANCE COMMITTEE CONSULTS WITH THE CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER, GENERAL COUNSEL AND CORPORATE TREASURER AND SUCH OTHER PERSONS THE FINANCE COMMITTEE MAY DESIGNATE TO REVIEW THE DRAFT FORM 990. SUBSEQUENT TO ITS REVIEW, THE FINANCE COMMITTEE REPORTS TO THE BOARD REGARDING ITS OVERSIGHT OF FORM 990. THE FINAL DRAFT IS PROVIDED TO THE FULL BOARD PRIOR TO FILING THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12C	THE EXECUTIVE COMMITTEE OF THE BOARD IS RESPONSIBLE FOR MONITORING CONFLICTS OF INTEREST INVOLVING TRUSTEES OR THE PRESIDENT & DIRECTOR OF THE CENTER. THE PRESIDENT & DIRECTOR OF THE CENTER IS RESPONSIBLE FOR MONITORING CONFLICTS OF INTEREST INVOLVING OTHER OFFICERS, SCIENTIFIC STAFF AND OTHER KEY PERSONNEL DESIGNATED BY THE PRESIDENT & DIRECTOR. UNDER THE FHCRC CONFLICT OF INTEREST POLICY AND RELATED GUIDELINES, AN ANNUAL CONFLICT OF INTEREST DISCLOSURE DOCUMENT AIMED AT DETERMINING FAMILY AND BUSINESS RELATIONSHIPS AND TRANSACTIONS THAT CONSTITUTE A CONFLICT OF INTEREST UNDER THE POLICY, IS DISTRIBUTED TO AND MUST BE COMPLETED BY ALL COVERED PERSONS. DISCLOSURES BY TRUSTEES AND THE PRESIDENT & DIRECTOR ARE REVIEWED BY THE OFFICE OF THE GENERAL COUNSEL WHO REPORTS ANY CONFLICTS TO THE EXECUTIVE COMMITTEE WITH RECOMMENDATIONS ON APPROPRIATE TERMS FOR A CONFLICT MANAGEMENT PLAN. CONFLICT MANAGEMENT PLANS FOR TRUSTEES AND THE PRESIDENT & DIRECTOR ARE REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AND SIGNED BY THE PERSON WITH THE CONFLICT OF INTEREST AND THE CHAIR OF THE BOARD. DISCLOSURE BY MEMBERS OF THE SCIENTIFIC STAFF, OFFICERS OTHER THAN THE PRESIDENT & DIRECTOR AND OTHER KEY PERSONNEL DESIGNATED BY THE PRESIDENT & DIRECTOR ARE REVIEWED BY THE OFFICE OF THE PRESIDENT & DIRECTOR, THE OFFICE OF THE GENERAL COUNSEL, AND THE DIRECTOR OF THE DIVISION IN WHICH THE PERSON HAS HIS OR HER PRIMARY APPOINTMENT OR RESPONSIBILITIES. IF A CONFLICT IS DETERMINED TO EXIST UNDER THE POLICY A WRITTEN CONFLICT MANAGEMENT PLAN IS RECOMMENDED BY THE OFFICE OF THE GENERAL COUNSEL AND APPROVED AND SIGNED BY THE OFFICE OF THE DIRECTOR, THE OFFICE OF THE GENERAL COUNSEL AND THE DIVISION DIRECTOR AS WELL AS THE PERSON WHO HAS THE CONFLICT. CONFLICT MANAGEMENT PLANS ARE DESIGNATED TO MANAGE, REDUCE AND ELIMINATE CONFLICTS TO PREVENT BIAS, IMPROPER INFLUENCE, OR MISUSE OF FHCRC OR GOVERNMENT RESOURCES. THE CONFLICT MANAGEMENT PLANS FOR TRUSTEES USUALLY REQUIRE THE AFFECTED TRUSTEE TO RECUSE HIMSELF OR HERSELF FROM VOTING ON ANY MATTERS INVOLVING THE AFFECTED TRANSACTION OR RELATIONSHIP ALTHOUGH HE OR SHE IS ALLOWED TO PROVIDE FACTUAL INFORMATION IF REQUESTED BY THE BOARD OF THE EXECUTIVE COMMITTEE. ALL TRANSACTIONS REQUIRING BOARD OR COMMITTEE APPROVAL MUST BE APPROVED BY A MAJORITY OF DISINTERESTED PERSONS. CONFLICT MANAGEMENT PLANS INVOLVING SCIENTIFIC STAFF, OFFICER OR OTHER KEY PERSONNEL USUALLY IMPOSE ONE OR MORE OF THE FOLLOWING CONDITIONS OR RESTRICTIONS: 1) PUBLIC DISCLOSURE OF THE INTEREST, 2) MONITORING OF RESEARCH BY INDEPENDENT REVIEWERS, 3) MODIFICATION OF THE RESEARCH PLAN, 4) DISQUALIFICATION FROM PARTICIPATION IN ALL OF OR A PORTION OF THE RESEARCH BY THE PERSON WITH THE CONFLICT OF INTEREST, 5) DIVESTURE OF THE INTEREST, 6) SEVERANCE OF THE RELATIONSHIP CREATING THE CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	COMPENSATION FOR THE PRESIDENT & DIRECTOR IS DETERMINED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE. THE COMPENSATION OF OTHER OFFICERS AND KEY PERSONNEL AT FHCRC IS DETERMINED BY THE PRESIDENT & DIRECTOR SUBJECT TO RATIFICATION BY THE COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE HAS DEVELOPED, CONSISTENT WITH THE ORGANIZATION'S PHILOSOPHY AND PRINCIPLES, GUIDELINES FOR DETERMINING COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE ALSO HIRES A QUALIFIED INDEPENDENT COMPENSATION SPECIALIST ("INDEPENDENT EXPERT") EVERY TWO YEARS TO REVIEW, ANALYZE AND PROVIDE BENCHMARKING DATA FOR THE TOTAL COMPENSATION PACKAGES OF ALL OFFICERS AND KEY EMPLOYEES. APPROPRIATE COMPARABILITY DATA IS OBTAINED FROM THE INDEPENDENT EXPERT. NO PERSON WITH A CONFLICT OF INTEREST MAY PARTICIPATE IN DETERMINING OR APPROVING ANY EXECUTIVE COMPENSATION. MEETINGS OF THE COMPENSATION COMMITTEE ARE DOCUMENTED IN MINUTES WHICH ARE APPROVED AT THE NEXT COMMITTEE MEETING. THE ABOVE PROCESS WAS LAST UNDERTAKEN IN 2012.
FORM 990, PART VI, SECTION C, LINE 19	WHILE FEDERAL TAX LAWS DO NOT MANDATE THAT THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS BE MADE AVAILABLE FOR PUBLIC INSPECTION, THE ORGANIZATION MAKES THESE DOCUMENTS AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 5:	NET UNREALIZED LOSSES ON INVESTMENTS: -25,915,220. ADJUSTMENT FOR DECONSOLIDATION OF CONTROLLED AFFLIATE (SVRF) -434,077. TOTAL TO FORM 990, PART XI, LINE 5: -26,349,297.	CHANGES IN NET ASSETS OR FUND BALANCES:

Schedule R IRS990ScheduleR

Form990 Schedule R Part II Form990ScheduleRPartII (3 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivities	Legal Domicile StateLegalDomicileState	Exempt Code SectionExemptCodeSection	Public Charity StatusPublicCharityStatus	Business Name Line1DirectControllingEntityName/BusinessNameLine1	Controlled OrgControlledOrg	Address Line1AddressForeign/AddressLine1	CityAddressForeign/City	CountryAddressForeign/Country	Legal Domicile Foreign CountryLegalDomicileForeignCountry	Postal CodeAddressForeign/PostalCode
SEATTLE VACCINE RESEARCH FUND
1100 FAIRVIEW AVENUE NORTH	SEATTLE	WA	98109	331111221	ANTI-RETROVITAL THERAPY FOR ELIGIBLE PARTICIPANTS	WA	501(C)(3)	LINE 11A, I	FRED HUTCHINSON CANCER RESEARCH CENTER	1
UPCID LTD
					RESEARCH AND EDUCATION ON CANCER AND INFECTIOUS DISEASES				FRED HUTCHINSON CANCER RESEARCH CENTER	1	POB 3935 MULAGO HOSPITAL UPPER MU	KAMPALA	UG	UG
HUTCHINSON CANCER RESEARCH INSTITUTE OF SOUTH AFRICA
					RESEARCH				FRED HUTCHINSON CANCER RESEARCH CENTER	1	6TH FLOOR 119 HERTZOG BLVD	FORESHORE, CAPETOWN	SF	SF	8001

Form990 Schedule R Part IV Form990ScheduleRPartIV

Name Of Related Org NameOfRelatedOrg

Field	Value	IRS element (for citing)
Business Name Line1	CHARITABLE REMAINDER TRUSTS (5)	BusinessNameLine1

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	1100 FAIRVIEW AVE NORTH	AddressLine1
City	SEATTLE	City
State	WA	State
ZIP Code	981091024	ZIPCode

Field	Value	IRS element (for citing)
Primary Activity	INVESTMENT	PrimaryActivity
Legal Domicile State	WA	LegalDomicileState

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	FRED HUTCHINSON CANCER RESEARCH CENTER	BusinessNameLine1

Field	Value	IRS element (for citing)
Type Of Entity	T	TypeOfEntity

Field	Value	IRS element (for citing)
Receipt Of Int Ann Rents Royalties	0	ReceiptOfIntAnnRentsRoyalties
Gift Grant Or Cap Contr To Other Org	0	GiftGrantOrCapContrToOtherOrg
Gift Grant Or Cap Contr Fr Other Org	0	GiftGrantOrCapContrFrOtherOrg
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrg
Loans Or Guarantees From Other Org	0	LoansOrGuaranteesFromOtherOrg
Sale Of Assets To Other Org	0	SaleOfAssetsToOtherOrg
Purchase Of Assets From Other Org	0	PurchaseOfAssetsFromOtherOrg
Exchange Of Assets	0	ExchangeOfAssets
Rental Of Facilities To Other Orgs	0	RentalOfFacilitiesToOtherOrgs
Rental Of Facilities Fr Other Orgs	0	RentalOfFacilitiesFrOtherOrgs
Perform Of Services For Other Orgs	1	PerformOfServicesForOtherOrgs
Perform Of Services By Other Orgs	1	PerformOfServicesByOtherOrgs
Sharing Of Facilities	0	SharingOfFacilities
Sharing Of Paid Employees	0	SharingOfPaidEmployees
Reimbursement Paid To Other Org	1	ReimbursementPaidToOtherOrg
Reimbursement Paid By Other Org	0	ReimbursementPaidByOtherOrg
Other Transfer To Other Org	1	OtherTransferToOtherOrg
Other Transfer From Other Org	0	OtherTransferFromOtherOrg

Transactions Related Orgs Table TransactionsRelatedOrgsTable (4 entries)

Transaction TypeTransactionType	Amount InvolvedAmountInvolved	Method Of Amt DeterminationMethodOfAmtDetermination
UPCID LTD
K	485217	BASED ON SPECIFIC COST CENTERS
UPCID LTD
O	540468	CIP COSTS INCURRED BY FH FOR UPCI
UPCID LTD
Q	425542	CASH TRANSFERS/ADVANCES TO UPCID
UPCID LTD
L	474321	PAYMENTS FOR RESEARCH SERVICES